US20050216062A1 - Multi-functional electrical stimulation system - Google Patents
Multi-functional electrical stimulation system Download PDFInfo
- Publication number
- US20050216062A1 US20050216062A1 US10/706,844 US70684403A US2005216062A1 US 20050216062 A1 US20050216062 A1 US 20050216062A1 US 70684403 A US70684403 A US 70684403A US 2005216062 A1 US2005216062 A1 US 2005216062A1
- Authority
- US
- United States
- Prior art keywords
- signal
- electrical stimulation
- output
- stage
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36031—Control systems using physiological parameters for adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
Definitions
- This invention relates generally to the electrical stimulation devices for effecting faradic, electromagnetic or other forms of electrical stimulation, and more particularly, to a multi-functional system for this purpose capable of selectively yielding electrical stimulation signals for a broad spectrum of different biological and biomedical applications as well as for other applications, such as electrophoresis.
- ES Electrical stimulation
- faradic stimulation a continuously intermittent or a continuous direct or alternating current or voltage is produced
- electromagnetic stimulation a current passing through a coil produces an electromagnetic field whose pattern depends on the wave form of the current.
- Electrode regeneration is employed to effect nerve regeneration, in neuromuscular research, in medical diagnosis and treatment, and in pulsed voltage electrophoresis. Such stimulation is also used in bone healing and in wound healing, as well as in pain relief by means of transcutaneous electrical nerve stimulation (TENS).
- TENS transcutaneous electrical nerve stimulation
- the use of ES to effect nerve regeneration is disclosed in the Zanakis et al. U.S. Pat. No. 4,774,967 as well as in the Borgens patent U.S. Pat. No. 4,919,140.
- constant current stimulators for direct cortical stimulation as well as electrical stimulators for nerve and muscle stimulation procedures which generate single or double pulses, or trains of such pulses.
- wave generators capable of selectively generating sine and square wave pulses suitable for other types of electrical stimulation.
- the signals produced thereby can also be used for electroporation, electrophoresis (preferably pulsed voltage electrophoresis) and iontophoresis as well as for electrochemical applications as in the treatment of cancer in which a current is passed through the tissue being treated.
- the signals can also be used to transdermal drug delivery.
- the main object of this invention is to provide a multi-functional electrical stimulation (ES) system adapted to yield output signals for effecting faradic, electromagnetic or other forms of electrical stimulation for a broad spectrum of different biological and bio-medical applications.
- ES electrical stimulation
- a significant advantage of a system in accordance with the invention is that it affords its user, whether a researcher, a diagnostician or a clinician, with whatever electrical stimulation signal is dictated by the specific type of electrical stimulation that is required. Thus if in conducting tests, a researcher needs to subject certain nerves to many different forms of electrical stimulation, the self-sufficient system, by itself and without accessories, is capable of supplying whatever electrical stimulation signals are appropriate.
- an object of this invention is to provide a multi-functional system of the above type that includes a measuring stage that measures and displays the electrical stimulation signal operating on the substance being treated and also indicates and displays signals issuing from sensors which sense conditions prevailing in the substance, such as pH and 02, whereby the user of the system is able to observe and monitor the effects of the electrical stimulation signal he has selected.
- Another object of this invention is to provide a highly-compact system of the above type which can be manufactured at relatively low cost.
- ES electrical stimulation
- the system includes an ES signal stage having a selector coupled to a plurality of different signal generators, each producing a signal having a distinct shape such as a sine, a square or sawtooth wave, or simple or complex pulse, the parameters of which are adjustable in regard to amplitude, duration, repetition rate and other variables.
- the signal from the selected generator in the ES stage is fed to at least one output stage where it is processed to produce a high or low voltage or current output of a desired polarity whereby the output stage is capable of yielding an electrical stimulation signal appropriate for its intended application.
- a measuring stage which measures and displays the electrical stimulation signal operating on the substance being treated as well as the outputs of various sensors which sense conditions prevailing in this substance whereby the user of the system can manually adjust it or have it automatically adjusted by feedback to provide an electrical stimulation signal of whatever type he wishes and the user can then observe the effect of this signal on a substance being treated.
- the signals from the ES signal stage are put on a bus from which they can be accessed by the output stages.
- the electrical stimulation signal yielded by the system can be used for applications other than those involving electrical stimulation, such as for electrophoresis and electroporation.
- the signals from the system can be used in applications requiring mechanical or acoustic waves by applying the signal to an appropriate transducer.
- FIG. 1 is a block diagram of a system in accordance with the invention having an ES stage, an output stage and a measuring stage;
- FIG. 2 is a block diagram of a basic version of a system for producing various electrical stimulation pulses
- FIG. 3 illustrates an example of a preset custom module
- FIG. 4A is a graph showing at the full power output of an amplifier a pulse having a rising edge
- FIG. 4B is a graph showing at the full power output of an amplifier a pulse having a falling edge
- FIG. 5 (Sections A & B) and FIG. 6 (Sections A & B), show an embodiment of a low voltage output stage for generating various analog pulses and their combinations from digital inputs.
- a system in accordance with the invention is composed of an ES signal stage 10 which at the user's discretion generates a signal shaft appropriate for a specific apparatus which is fed to an output stage 11 .
- Output stage 11 processes the electrical stimulation signals selected by the user to yield a types of signal suitable for its intended biological or biomedical application.
- a measuring stage 12 which measures and displays the electrical stimulation signal operating on the biological, substance being subjected thereto, and/or its electrical parameters as well as the output of various sensors which sense conditions prevailing in this substance whereby the user is able to observe, monitor as well as adjust the effects of the stimulation signal he has selected on the substance being treated.
- ES signal stage 10 includes signal generators 13 to 17 producing signals of different shape.
- Generator 13 is a pulse wave generator generating one or more rectangular pulses, such as pulses A and B of different width which can be outputted separately or can be added or subtracted from each other to yield A or B, A plus B or A minus B.
- Generator 14 is a sine wave generator, generator 15 generates a triangular or sawtooth wave, and generator 16 produces a ramp voltage wave.
- Generator 17 yields a wave of any arbitrary shape.
- the signal generators are capable of generating a minimum one pulsatory signal or a greater numbers of pulsatory signals, or of generating a gated signal with a minimum of one period or a greater number of periods, with individual adjustments of electrical parameters.
- the parameters of the respective waves produced by signal generators 13 to 17 can be adjusted in frequency, pulse width, amplitude and repetition rate, or with respect to any other variable.
- a mechanical or electronic selector switch 20 Coupled to generators 13 to 17 and activated by a signal applied thereto at terminal 20 A is a mechanical or electronic selector switch 20 .
- the output signal from the signal generator selected by a switch 20 is applied through a line 21 to output stage 11 .
- the line is preferably a bus system.
- the ES signal stage 10 is preferably miniaturized and may take the form of a hybrid device or a single ASIC chip (Application Specific Integrated Circuit).
- Output stage 11 includes a mechanical or electronic selector switch 22 which applies the ES signal from stage 10 either to a low voltage processor 23 , a high voltage processor 24 , a current processor 25 , or a power processor 26 to put the ES signal in a form appropriate to the intended application for electrical stimulation.
- all signals can be accessed simultaneously by one or more output stages through a system bus.
- a combination of one or more signal generators in the ES signal stage with one or more of the output stag can be miniaturized.
- the output of the processor 23 , 24 , 25 or 26 chosen by selector switch 22 is fed to a modulator 27 coupled to an amplitude control unit 28 which modifies the amplitude of the signal applied thereto.
- the output of amplitude-control unit 28 is applied to a polarity control unit 29 in which the electrical stimulation signal is given a positive or negative polarity or is converted to an AC signal, depending on the intended application for the electrical stimulation signal.
- Each output stage can be configured with either multiple output terminals 30 or with a single output.
- the multiple outputs make it possible to run several parallel experiments or processes concurrently.
- the ES system can be miniaturized to form a single ES component comprising signal generators and miniaturized output circuitry packaged together.
- a functional sketch of one such ES component 31 is shown in FIG. 2
- an example of a customized module 32 with a preset waveform and preset electrical parameters is shown in FIG. 3 .
- a preferred version of the ES component includes a sophisticated digital pulse generator on a chip and an analog circuitry to define complex pulse patterns, with amplitudes up to ⁇ 10V.
- the output can be fed into any number of desirable output stages, which can be integrated into the same component or be independent proprietary devices, e.g., voltage controlled or current controlled output stages with various voltage/current amplitudes, high frequency output stage with various bandwidths depending on a specific application, various power output stages, etc.
- Waveforms other than pulse patterns, as well as modulated signals can be part of such a “system on a chip.”
- a digital ASIC The design of a digital ASIC consists of several blocks, which can be either used together to create a sophisticated pulse generator for biomedical applications, or can be used in any number of other applications requiring a pulse signal.
- Each of these blocks or functional modules can provide an independent waveform or pulse (A pulse; B pulse; square wave; time delay; etc).
- a basic one output version of the signal generator delivers two independent pulses A and B with digitally adjustable pulse widths, the same pulse repetition rate, and with an adjustable delay between them or for each of them. It also delivers a square wave and timing for alternate and biphasic pulses and two pulse trains. In a two or more output version, individual pulses can have independently set repetition rates.
- All timing parameters of the pulses preferably are fully programmable by a user via hardware or via software-generated inputs. For example, one can adjust timing using thumbwheels or switches connected via parallel inputs of the ES component, or by using software and a serial, parallel, or custom interface as an input (or a combination of analog and digital inputs can be used).
- the ES component can include both a parallel and a serial interface so that the user can define the optimal means for each application.
- the analog output amplitudes of the ES component or ES system can be adjusted for each pulse separately (via hardware or software, as above). At the same time, a specific DC level can be added; i.e., signal can be shifted up or down from zero line.
- the alternate and biphasic pulses are designed so that only one adjustment for both positive and negative pulse width and amplitude is required, which results in guaranteed symmetrical signals.
- the output preferably varies from 0 to ⁇ 10 V and is set digitally.
- Rise time and fall time for a full power response in a standard speed implementation is 336 ns and 360 ns, respectively (see FIGS. 4A and 4B ).
- the corresponding numbers are 186 ns and 163 ns, respectively.
- the ES component can be also interfaced to a current output stage with single or multiple outputs and current levels of ⁇ 200 ⁇ A or another current level depending upon the particular application of use. In practice an isolated power supply for both analog and digital signals can be used.
- An optional galvanic isolation can be added between the digital and analog parts of the ES component using standard electronic components.
- This isolation system in combination with an isolated power supply for the analog signals, provides an isolated output from the stimulator.
- This aspect of the invention is a detailed solution for generating fast, high accuracy analog pulses with predefined pulse amplitudes, as well as for combining at least two single pulses to a pulse pattern. It is one of possible specific solutions which can be implemented as a part of the overall system design.
- the “Inputs and Outputs” section below can be viewed as a design example to show the concept behind creating an analog pulse pattern based on at least two pulse signals A and B. Each of the A and B pulses has a separate setting of the pulse width and pulse amplitude. The same concept is used to create a highly accurate biphasic or alternating pulses based on a single amplitude setting for both positive and negative part of the signal and thus eliminating the risk for an unbalanced charge delivered to the experimental system.
- Digital pulses A and B have a pulse width TA and TB and a delay TD between them generated in hardware (or software) and together with the d-c voltages preset to the desired amplitudes for each pulse signal constitute the input signals to this stage.
- the design depicted in the “Inputs and Outputs” section uses a voltage reference and two 12-bit DACs on the same chip to set carefully controlled d-c levels.
- the digital pulses A and B are used to control opening and closing of a switch on the output of each of the DACS, respectively, and thus shaping A and B pulse waves.
- the correct amplitudes are set by the DACs and the correct analog pulse width is set by the length of time the appropriate analog switch is closed. When the switch is open, the output voltage for A and B pulse, respectively, is set to zero. Both waveforms are then passed through an adding circuitry. A d-c level can be added at the same time.
- An optional set of preprogrammed modules can be used independently or added to the basic ES component or even made a part of the ASIC design; for example, a pulse train used clinically for bone healing (timing parameters; repetition rate ⁇ 15 Hz, pulse train length ⁇ 5 ms, positive pulse with ⁇ 200 us, negative pulse width ⁇ 24 us, Electro-Biology, Inc. Parsippany, N.J.).
- This conventional bone-healing signal measured with a pick-up coil, is delivered from an electromagnetic field (EMF) stimulator.
- EMF electromagnetic field
- a preprogrammed ES module allows for testing of the biological effects of the same or a similar electrical signal, but delivered through electrodes, without a strong magnetic field component, in addition to or instead of both experimental and clinical use in EMF stimulators.
- the cost of the equipment presently required will be significantly reduced by using pulse generator ASIC-based system of this invention rather than buying several independent stimulators.
- the flexible pulse generator ASIC and the ES component of this invention can form the basis for an ES device as described herein, and can be used by electrical stimulation equipment manufacturers as an inexpensive off-the-shelf component to simplify production, cut costs, save space, and miniaturize existing systems.
- the present invention improves the overall system reliability by providing the whole system as a single well-tested component.
- the present invention using an ASIC reduces the power requirements, thus permitting battery operation in applications where high current/voltage output is not required, which also allows for a further miniaturization of the total digital/analog system and adds a safety feature for clinical applications.
- Pulse Generator (a) Square pulse repetition rate (50% duty cycle) (b) Single pulse A repetition rate & pulse width (c) Dual pulses A and B individually set pulse width single output: same repetition rate for both A and B dual outputs: same or individually set repetition rates (d) Alternate pulse set automatically by setting pulse A parameters (e) Biphasic pulse set automatically setting pulse A parameters (f) A + B same repetition rate for both individual pulse widths (g) A ⁇ B same repetition rate for both, individual pulse widths (h) Pulse train repetition rate of pulse train, and either pulse width of the pulse train or number of individual pulses in the train (i) User defined all applicable timing parameters II. Sinewave generator frequency III. Sawtooth, triangle. frequency, rise and fall ramp waveform generators times IV Arbitrary waveform generator all timing parameters Inputs and Outputs:
- FIG. 5 (Sections A & B) there are two, 2 mm, 40 pin headers from which signal inputs, signal outputs, and power connect to the printed circuit board (pcb).
- the board requires two supplies to operate, +15 VDC and ⁇ 15 VDC. Power and Ground comes in through P 2 .
- +5 VDC necessary for logic circuitry and interface is derived from onboard regulator U 15 from the +15 VDC supply.
- Pulse waveforms are generated within the stimulator by appropriate switching of 8-to 1 multiplexers U 1 , U 2 , U 17 , and U 3 .
- Logic level pulses TA, TB, SQ, TA 1 , and TA 2 are selected by addressing U 1 and US with signals WV-A, WV-B, and WV-C.
- U 17 and U 3 sets pulse polarity and select between UA and UB amplitudes.
- U 4 and U 5 comprise the “logic”′ which creates the waveform and routes the resultant signal to the output amplifiers.
- switch 1 of U 5 When the output of U 1 pin 8 is high, switch 1 of U 5 is enabled, presenting the level determined by U 17 to the output amplifiers, This also breaks switch 2 of U 5 which prevents contention with the output of U 3 .
- the level determined by U 3 pin 8 is presented to the output amplifiers when U 1 pin 8 is low and U 2 pin 8 is high.
- switch 4 of U 5 is enabled, thereby shorting the input of the output amplifiers to ground. This charges or resets the node to 0 VDC.
- the dual operation amplifier IC, U 9 , and associated passive components comprise the output amplifiers.
- Pin 2 of U 9 is a summing junction. Pulses described above induce current through R 3 into the inverting node of the first amplifier (pin 2 ). If DC_level is set, d-c voltage appearing at the junction of R 4 and U 8 pin 14 induces a d-c current into the same inverting junction thereby creating a d-c voltage bias level at the output. If DC-level is not set, R 4 is grounded through switch 2 of U 8 . No d-c bias appears at the output in this case. OUT is the output of the first operational amplifier. This represents the inverted pulsed signal output train.
- the second amplifier of U 9 is also an inverter which provides a non-inverted pulse train. Switches 3 and 4 of U 8 allow for the polarity selection of OUT 2 . A logic low selects the non-inverting output. A logic high selects the inverted output. Upon selecting the inverting output illuminates LED 1 .
- a 14 bit multiplying DAC, U 6 , operational amplifier U 7 , and associated passive components form the d-c level circuit.
- U 6 is a current output DAC configured for bipolar output.
- the VREF input is determined by the level of UA. Since UA ranges from 0 to +10V, the d-c level circuit can range from 0 VDC to ⁇ 10 VDC.
- the 14-bit DAC bus interfaces directly to P 1 .
- Three control signals LVLDAC/LDAC, LVLDAC/CS, and LVLDAC WR allow for addressing the DAC and writing levels. Refer to the AD75538 data sheet, for more detailed information on this part.
- U 14 is an accurate and stable +10,00 volt reference.
- Resistors R 16 through R 29 form a precision resistive divider to derive 6 other voltage levels.
- U 10 and U 11 allow for the selection of +10,00V, 5.000V, 1.000V, 0.3000V, 0.2000V, 0.1000V, 0.0100V or ground for the UA and UB channels.
- Signals UA_AO, UA_A 1 , UA_A 2 , UB_AO, UB_A 1 , and, UB_A 2 determine the UA and UB reference levels respectively.
- a dual op amp, U 13 converts the DAC's A channel current output to +UA and ⁇ UA voltages.
- U 16 converts the DAC's B channel current output to +UB and ⁇ UB voltages.
- U 12 is a dual 12-bit multiplying DAC arranged for unipolar outputs.
- U 12 shares the same data bus per FIGS. 5B & 6B as U 6 . It is addressed and controlled by the SAV_/CSA, SAV_/CSB, and SAV_/WRDAC signals.
- ⁇ UA and ⁇ UB are used by the waveform generating circuits to set signal amplitude and polarity.
- the UA level is also used as the reference for the level DAC. Please refer to the datasheets for the AD7538, AD7547, ADG408, ADG433, AD712,78LO5, and LT1235 components.
- a ⁇ 10V voltage output is a generic output stage useful for several neuromuscular and other applications.
- This output stage preferably includes an output amplifier sage sufficient to drive a load.
- a +50V voltage output stage can be used in the alternative as a generic output stage useful for several neuromuscular and other applications. It can be limited to a lower voltage than the maximum ⁇ 50V by choosing a lower voltage power supply and changing values of appropriate components such as resistors. This higher voltage output stage is especially useful for the optimization of low voltage electroporation, and it can be packaged together with the ES component.
- Higher voltage output stages in the range up to 250V, or even higher up to 1,000V, or up to a few thousand volts (preferable about 6,000V), and ranges there between, can be used (or can be specially useful) for pulsed voltage electrophoresis or magnetic stimulation of the brain.
- Magnetoresistive sensors such as those pioneered by Honeywell, offer the various advantages over other forms of magnetic sensors, such as flux gates or coils: small dimensions, such as needed in biomedical applications; high sensitivity, allowing for a long distance between the item being sensed and the device (dependent on its ferromagnetic mass); immunity to electromagnetic noise and interferences due to the small internal impedance; and better reliability because it is a solid state solution with no moving parts; and lower development costs because components can be easily incorporated into board-level products.
- a magnetic probe useful with the present invention is preferably a 3-axis magnetic sensor working in the range 0 to 10 Gauss, preferably 0 to 20 Gauss, or ⁇ 40 Gauss, with resolution better than 100 ⁇ Gauss, and diameter of approximately 1 cm.
- Magnetoresistive transducers are made of long strips of thin ferromagnetic films of material such as per Malloy, a nickel-iron alloy. These films are deposited and fabricated using standard semiconductor technology on silicon wafers. The strips are several hundred Angstrom (150-500) in thickness, several tens of microns wide (10-50) and several hundred to several thousand microns long, and can be used to make the magnetic probe useful for this invention.
- An analog output magnetic sensor hybrid (e.g., model number HMC2003, available from Honeywell) is a “building block” product that allows to use an independent micro-controller, while obtaining the resolution and sensitivity of conventional magnetoresistive technology.
- the Honeywell device comes in a small 20 pin 600 mil dual-in-line package that combines the magnetic sensing components with signal conditioning electronics and amplification for each channel.
- the sensor can be used in a closed mode operation.
- the probe includes the ability to measure temperature.
- Another embodiment includes a miniature 3-axis probe ( ⁇ 3 mm in diameter) with amplification. Both these sensors can be utilized in both ac and dc mode.
- the user chooses the particular signal or waveform appropriate to the intended electrical stimulation application.
- the user uses a dial or switches attached to the system or software communicating with the system, and sets up specific timing and amplitude parameters via the serial or parallel input ports 18 and 19 .
- the user also selects output stage 11 with either single or multiple output ports.
- Measuring stage 12 by means of a sensor input terminal 12 A, allows the use of appropriate sensors to sense the electrical stimulation signal passing through the organic substance being treated and environmental parameters, such as current, magnetic field, voltage, impedance, temperature, pH, gas (O 2 , CO 2 , etc.) as well as various biochemical substances involved locally in or resulting from the procedure at the site where the signal is administered or at another site.
- environmental parameters such as current, magnetic field, voltage, impedance, temperature, pH, gas (O 2 , CO 2 , etc.) as well as various biochemical substances involved locally in or resulting from the procedure at the site where the signal is administered or at another site.
- the various sensors for this purpose include sensing electrodes, pick-up coils, temperature-sensitive devices, magnetic probes, and biosensors, all which yield a signal which is applied to input terminal 12 A this terminal is connected to a signal conditioner 33 whose output is coupled to a measuring and display unit 34 whose output is fed to a video screen or other indicator.
- a display control 35 and a DMM control 36 Associated with unit 34 is a display control 35 and a DMM control 36 .
- ES system in accordance with the invention consists of a digital, high accuracy pulse generator capable of generating several either dependent or independent, synchronized rectangular pulses, available simultaneously, through a selector or preferably on a system bus.
- One or more output stages can be placed anywhere on the system bus and be accessed by a user. The choice the user makes may be threefold; either one specific output stage is plugged into the system; a specific output stage is selected among several output stages available using either a dial, a selector, or other means; or several output stages are used in parallel, either independently or triggered by each other.
- the ES system can be also triggered by an external process or event, e.g., a physiological event, and will deliver either a preset signal in response to such a stimuli, or a signal which can be continuously modified by a triggering signal with respect to both timing and amplitude (and possibly shape).
- a preset delay between a triggering signal and a response signal can be made available.
- Signals other than pulses can also be made available and accessible either through a selector or on the bus, including gated and/or modulated signals of various shapes. All of the signals can be fed to the output stages in the following ways: one signal to one output stage (with a single or multiple outputs); one signal to several output stages (identical or different); several signals to one output stage (for a complex signal shape or in case of multiple outputs); several signals to several output stages (identical or different).
- output stages can have simultaneous access to identical or different signals creating the following system configurations:
Abstract
A multi-functional electrical stimulation (ES) system adapted to yield output signals for effecting faradic, electromagnetic, or other forms of electrical stimulation for a broad spectrum of different biological and biomedical applications. The system includes and ES signal stage having a selector coupled to a plurality of different signal generators, each generator producing a signal having a distinct shape such as a sine, a square or sawtooth wave or a simple or complex pulse form, the parameters of which are adjustable in regard to amplitude, duration, repetition rate and other variables. The signal from the selected generator in the ES stage is fed to at least one output stage where it is processed to produce a high or low voltage or current output of a desired polarity whereby the output stage is capable of yielding an electrical stimulation signal appropriate for its intended application. Also included in the system is a measuring stage which measures and displays the electrical stimulation signal operating on the substance being treated as well as the outputs of various sensors which sense conditions prevailing in this substance whereby the user of the system can adjust it to yield an electrical stimulation signal of whatever type he wishes and can then observe the effects of this signal on a substance being treated. A multi-functional electrical stimulation (ES) system adapted to yield output signals for effecting faradic, electromagnetic, or other forms of electrical stimulation for a broad spectrum of different biological and biomedical applications. The system includes and ES signal stage having a selector coupled to a plurality of different signal generators, each generator producing a signal having a distinct shape such as a sine, a square or sawtooth wave or a simple or complex pulse form, the parameters of which are adjustable in regard to amplitude, duration, repetition rate and other variables. The signal from the selected generator in the ES stage is fed to at least one output stage where it is processed to produce a high or low voltage or current output of a desired polarity whereby the output stage is capable of yielding an electrical stimulation signal appropriate for its intended application. Also included in the system is a measuring stage which measures and displays the electrical stimulation signal operating on the substance being treated as well as the outputs of various sensors which sense conditions prevailing in this substance whereby the user of the system can adjust it to yield an electrical stimulation signal of whatever type he wishes and can then observe the effects of this signal on a substance being treated.
Description
- This application is a continuation of application Ser. No. 013,049, filed Jan. 27, 1998, the disclosure and drawings of which are incorporated herein by reference.
- This application is related to our provisional application Ser. No. 60/034,869, filed on Jan. 27, 1997, entitled “ELECTRICAL STIMULATOR AND AMPLIFIER”, the entire disclosure of which is incorporated herein by reference.
- 1. Field of Invention
- This invention relates generally to the electrical stimulation devices for effecting faradic, electromagnetic or other forms of electrical stimulation, and more particularly, to a multi-functional system for this purpose capable of selectively yielding electrical stimulation signals for a broad spectrum of different biological and biomedical applications as well as for other applications, such as electrophoresis.
- 2. Status of Prior Art
- Electrical stimulation (ES) is widely used in biological and biomedical research as well as in diagnostics and in clinical treatment. In faradic stimulation a continuously intermittent or a continuous direct or alternating current or voltage is produced, whereas in electromagnetic stimulation, a current passing through a coil produces an electromagnetic field whose pattern depends on the wave form of the current.
- Electrical stimulation is employed to effect nerve regeneration, in neuromuscular research, in medical diagnosis and treatment, and in pulsed voltage electrophoresis. Such stimulation is also used in bone healing and in wound healing, as well as in pain relief by means of transcutaneous electrical nerve stimulation (TENS). The use of ES to effect nerve regeneration is disclosed in the Zanakis et al. U.S. Pat. No. 4,774,967 as well as in the Borgens patent U.S. Pat. No. 4,919,140.
- Researchers in the biological and medical sciences, physiotherapists, and clinicians who make use of ES require electrical stimulators of a type suitable for the activities in which they are engaged. Thus neurological investigators who seek to non-invasively stimulate deep nerves make use of commercially available magnetic stimulators which produce a high-intensity magnetic field pulse for this purpose.
- Also commercially available are constant current stimulators for direct cortical stimulation as well as electrical stimulators for nerve and muscle stimulation procedures which generate single or double pulses, or trains of such pulses. And commercially available are wave generators capable of selectively generating sine and square wave pulses suitable for other types of electrical stimulation.
- But what is not available to researchers and others who make use of electrical stimulation is a multi-functional system capable of yielding an electrical stimulation signal that is appropriate for whatever biological or biomedical application is the concern of the user of the system.
- Let us assume, by way of example, that a researcher is engaged in a neurological research program in the course of which it becomes necessary to conduct tests on the effects of many different types of electrical stimuli on a certain set of nerves. The researcher would then have to assemble from different commercial sources the several electrical stimulators of different types called for by this program. This burdensome requirement adds substantially to the cost of conducting this research and to its space demands.
- While the invention will be described herein as a system for producing electrical stimulating signals, the signals produced thereby can also be used for electroporation, electrophoresis (preferably pulsed voltage electrophoresis) and iontophoresis as well as for electrochemical applications as in the treatment of cancer in which a current is passed through the tissue being treated. The signals can also be used to transdermal drug delivery.
- In view of the foregoing, the main object of this invention is to provide a multi-functional electrical stimulation (ES) system adapted to yield output signals for effecting faradic, electromagnetic or other forms of electrical stimulation for a broad spectrum of different biological and bio-medical applications.
- A significant advantage of a system in accordance with the invention is that it affords its user, whether a researcher, a diagnostician or a clinician, with whatever electrical stimulation signal is dictated by the specific type of electrical stimulation that is required. Thus if in conducting tests, a researcher needs to subject certain nerves to many different forms of electrical stimulation, the self-sufficient system, by itself and without accessories, is capable of supplying whatever electrical stimulation signals are appropriate.
- Also an object of this invention is to provide a multi-functional system of the above type that includes a measuring stage that measures and displays the electrical stimulation signal operating on the substance being treated and also indicates and displays signals issuing from sensors which sense conditions prevailing in the substance, such as pH and 02, whereby the user of the system is able to observe and monitor the effects of the electrical stimulation signal he has selected.
- Another object of this invention is to provide a highly-compact system of the above type which can be manufactured at relatively low cost.
- Briefly stated, these objects are attained by a multi-functional electrical stimulation (ES) system adapted to yield output signals for effecting faradic, electromagnetic or other forms of electrical stimulation for a broad spectrum of different biological and biomedical applications. The system includes an ES signal stage having a selector coupled to a plurality of different signal generators, each producing a signal having a distinct shape such as a sine, a square or sawtooth wave, or simple or complex pulse, the parameters of which are adjustable in regard to amplitude, duration, repetition rate and other variables.
- The signal from the selected generator in the ES stage is fed to at least one output stage where it is processed to produce a high or low voltage or current output of a desired polarity whereby the output stage is capable of yielding an electrical stimulation signal appropriate for its intended application. Also included in the system is a measuring stage which measures and displays the electrical stimulation signal operating on the substance being treated as well as the outputs of various sensors which sense conditions prevailing in this substance whereby the user of the system can manually adjust it or have it automatically adjusted by feedback to provide an electrical stimulation signal of whatever type he wishes and the user can then observe the effect of this signal on a substance being treated.
- In another embodiment of the system, the signals from the ES signal stage are put on a bus from which they can be accessed by the output stages.
- The electrical stimulation signal yielded by the system can be used for applications other than those involving electrical stimulation, such as for electrophoresis and electroporation. Or the signals from the system can be used in applications requiring mechanical or acoustic waves by applying the signal to an appropriate transducer.
- For a better understanding of the invention, as well as other objects and further features thereof, reference is made to the following detailed description to be read in conjunction with the accompanying drawing, wherein:
-
FIG. 1 is a block diagram of a system in accordance with the invention having an ES stage, an output stage and a measuring stage; -
FIG. 2 is a block diagram of a basic version of a system for producing various electrical stimulation pulses; -
FIG. 3 illustrates an example of a preset custom module; -
FIG. 4A is a graph showing at the full power output of an amplifier a pulse having a rising edge; -
FIG. 4B is a graph showing at the full power output of an amplifier a pulse having a falling edge, and -
FIG. 5 (Sections A & B) andFIG. 6 (Sections A & B), show an embodiment of a low voltage output stage for generating various analog pulses and their combinations from digital inputs. - A system in accordance with the invention, as shown in
FIG. 1 , is composed of anES signal stage 10 which at the user's discretion generates a signal shaft appropriate for a specific apparatus which is fed to anoutput stage 11.Output stage 11 processes the electrical stimulation signals selected by the user to yield a types of signal suitable for its intended biological or biomedical application. - Also provided is a
measuring stage 12 which measures and displays the electrical stimulation signal operating on the biological, substance being subjected thereto, and/or its electrical parameters as well as the output of various sensors which sense conditions prevailing in this substance whereby the user is able to observe, monitor as well as adjust the effects of the stimulation signal he has selected on the substance being treated. -
ES signal stage 10 includessignal generators 13 to 17 producing signals of different shape.Generator 13 is a pulse wave generator generating one or more rectangular pulses, such as pulses A and B of different width which can be outputted separately or can be added or subtracted from each other to yield A or B, A plus B or Aminus B. Generator 14 is a sine wave generator,generator 15 generates a triangular or sawtooth wave, andgenerator 16 produces a ramp voltage wave.Generator 17 yields a wave of any arbitrary shape. The signal generators are capable of generating a minimum one pulsatory signal or a greater numbers of pulsatory signals, or of generating a gated signal with a minimum of one period or a greater number of periods, with individual adjustments of electrical parameters. - By means of a
serial input port 18 toES stage 10 or a set ofparallel input ports 19, the parameters of the respective waves produced bysignal generators 13 to 17 can be adjusted in frequency, pulse width, amplitude and repetition rate, or with respect to any other variable. Coupled togenerators 13 to 17 and activated by a signal applied thereto atterminal 20A is a mechanical orelectronic selector switch 20. The output signal from the signal generator selected by aswitch 20 is applied through aline 21 tooutput stage 11. In practice, the line is preferably a bus system. - The
ES signal stage 10 is preferably miniaturized and may take the form of a hybrid device or a single ASIC chip (Application Specific Integrated Circuit).Output stage 11 includes a mechanical orelectronic selector switch 22 which applies the ES signal fromstage 10 either to alow voltage processor 23, ahigh voltage processor 24, acurrent processor 25, or apower processor 26 to put the ES signal in a form appropriate to the intended application for electrical stimulation. In-a preferred version, all signals can be accessed simultaneously by one or more output stages through a system bus. In practice, a combination of one or more signal generators in the ES signal stage with one or more of the output stag can be miniaturized. - The output of the
processor selector switch 22 is fed to amodulator 27 coupled to anamplitude control unit 28 which modifies the amplitude of the signal applied thereto. The output of amplitude-control unit 28 is applied to apolarity control unit 29 in which the electrical stimulation signal is given a positive or negative polarity or is converted to an AC signal, depending on the intended application for the electrical stimulation signal. - Each output stage can be configured with either
multiple output terminals 30 or with a single output. The multiple outputs make it possible to run several parallel experiments or processes concurrently. - As previously mentioned, the ES system can be miniaturized to form a single ES component comprising signal generators and miniaturized output circuitry packaged together. A functional sketch of one
such ES component 31 is shown inFIG. 2 , and an example of a customizedmodule 32 with a preset waveform and preset electrical parameters is shown inFIG. 3 . - A preferred version of the ES component includes a sophisticated digital pulse generator on a chip and an analog circuitry to define complex pulse patterns, with amplitudes up to ±10V. The output can be fed into any number of desirable output stages, which can be integrated into the same component or be independent proprietary devices, e.g., voltage controlled or current controlled output stages with various voltage/current amplitudes, high frequency output stage with various bandwidths depending on a specific application, various power output stages, etc. Waveforms other than pulse patterns, as well as modulated signals can be part of such a “system on a chip.”
- The design of a digital ASIC consists of several blocks, which can be either used together to create a sophisticated pulse generator for biomedical applications, or can be used in any number of other applications requiring a pulse signal. Each of these blocks or functional modules can provide an independent waveform or pulse (A pulse; B pulse; square wave; time delay; etc). A basic one output version of the signal generator delivers two independent pulses A and B with digitally adjustable pulse widths, the same pulse repetition rate, and with an adjustable delay between them or for each of them. It also delivers a square wave and timing for alternate and biphasic pulses and two pulse trains. In a two or more output version, individual pulses can have independently set repetition rates.
- Several of these independent signal generators can be combined into a multi-output device. All timing parameters of the pulses preferably are fully programmable by a user via hardware or via software-generated inputs. For example, one can adjust timing using thumbwheels or switches connected via parallel inputs of the ES component, or by using software and a serial, parallel, or custom interface as an input (or a combination of analog and digital inputs can be used). The ES component can include both a parallel and a serial interface so that the user can define the optimal means for each application.
- The analog output amplitudes of the ES component or ES system can be adjusted for each pulse separately (via hardware or software, as above). At the same time, a specific DC level can be added; i.e., signal can be shifted up or down from zero line. The alternate and biphasic pulses are designed so that only one adjustment for both positive and negative pulse width and amplitude is required, which results in guaranteed symmetrical signals.
- In the circuits shown in
FIGS. 5 and 6 , the output preferably varies from 0 to ±10 V and is set digitally. Rise time and fall time for a full power response in a standard speed implementation is 336 ns and 360 ns, respectively (seeFIGS. 4A and 4B ). For a 1.0 V pulse response, the corresponding numbers are 186 ns and 163 ns, respectively. The ES component can be also interfaced to a current output stage with single or multiple outputs and current levels of ±200 μA or another current level depending upon the particular application of use. In practice an isolated power supply for both analog and digital signals can be used. - An optional galvanic isolation can be added between the digital and analog parts of the ES component using standard electronic components. This isolation system, in combination with an isolated power supply for the analog signals, provides an isolated output from the stimulator.
- Pulse Generation:
- This aspect of the invention is a detailed solution for generating fast, high accuracy analog pulses with predefined pulse amplitudes, as well as for combining at least two single pulses to a pulse pattern. It is one of possible specific solutions which can be implemented as a part of the overall system design. The “Inputs and Outputs” section below can be viewed as a design example to show the concept behind creating an analog pulse pattern based on at least two pulse signals A and B. Each of the A and B pulses has a separate setting of the pulse width and pulse amplitude. The same concept is used to create a highly accurate biphasic or alternating pulses based on a single amplitude setting for both positive and negative part of the signal and thus eliminating the risk for an unbalanced charge delivered to the experimental system.
- Digital pulses A and B have a pulse width TA and TB and a delay TD between them generated in hardware (or software) and together with the d-c voltages preset to the desired amplitudes for each pulse signal constitute the input signals to this stage. The design depicted in the “Inputs and Outputs” section uses a voltage reference and two 12-bit DACs on the same chip to set carefully controlled d-c levels. The digital pulses A and B are used to control opening and closing of a switch on the output of each of the DACS, respectively, and thus shaping A and B pulse waves. The correct amplitudes are set by the DACs and the correct analog pulse width is set by the length of time the appropriate analog switch is closed. When the switch is open, the output voltage for A and B pulse, respectively, is set to zero. Both waveforms are then passed through an adding circuitry. A d-c level can be added at the same time.
- An optional set of preprogrammed modules, based on the architecture of the basic ES component, can be used independently or added to the basic ES component or even made a part of the ASIC design; for example, a pulse train used clinically for bone healing (timing parameters; repetition rate −15 Hz, pulse train length −5 ms, positive pulse with −200 us, negative pulse width −24 us, Electro-Biology, Inc. Parsippany, N.J.). This conventional bone-healing signal, measured with a pick-up coil, is delivered from an electromagnetic field (EMF) stimulator. A preprogrammed ES module allows for testing of the biological effects of the same or a similar electrical signal, but delivered through electrodes, without a strong magnetic field component, in addition to or instead of both experimental and clinical use in EMF stimulators. In situations with multiple parallel experiments, the cost of the equipment presently required will be significantly reduced by using pulse generator ASIC-based system of this invention rather than buying several independent stimulators.
- The flexible pulse generator ASIC and the ES component of this invention can form the basis for an ES device as described herein, and can be used by electrical stimulation equipment manufacturers as an inexpensive off-the-shelf component to simplify production, cut costs, save space, and miniaturize existing systems. The present invention improves the overall system reliability by providing the whole system as a single well-tested component. The present invention using an ASIC reduces the power requirements, thus permitting battery operation in applications where high current/voltage output is not required, which also allows for a further miniaturization of the total digital/analog system and adds a safety feature for clinical applications.
- The following are examples of signal generators that can be incorporated in the
ES signal stage 10, and the respective variable timing parameters of these generators:I. Pulse Generator (a) Square pulse repetition rate (50% duty cycle) (b) Single pulse A repetition rate & pulse width (c) Dual pulses A and B individually set pulse width single output: same repetition rate for both A and B dual outputs: same or individually set repetition rates (d) Alternate pulse set automatically by setting pulse A parameters (e) Biphasic pulse set automatically setting pulse A parameters (f) A + B same repetition rate for both individual pulse widths (g) A − B same repetition rate for both, individual pulse widths (h) Pulse train repetition rate of pulse train, and either pulse width of the pulse train or number of individual pulses in the train (i) User defined all applicable timing parameters II. Sinewave generator frequency III. Sawtooth, triangle. frequency, rise and fall ramp waveform generators times IV Arbitrary waveform generator all timing parameters
Inputs and Outputs: - Referring now to
FIG. 5 , (Sections A & B) there are two, 2 mm, 40 pin headers from which signal inputs, signal outputs, and power connect to the printed circuit board (pcb). The board requires two supplies to operate, +15 VDC and −15 VDC. Power and Ground comes in through P2. +5 VDC necessary for logic circuitry and interface is derived from onboard regulator U15 from the +15 VDC supply. - Pulse waveforms are generated within the stimulator by appropriate switching of 8-to 1 multiplexers U1, U2, U17, and U3. Logic level pulses TA, TB, SQ, TA1, and TA2 are selected by addressing U1 and US with signals WV-A, WV-B, and WV-C. U17 and U3 sets pulse polarity and select between UA and UB amplitudes.
TABLE 1 WV-A WV-B WV-C PULSE AMPLITUDE 0 0 0 Constant “ON” Constant UB 0 0 1 TA, “0” Pulsed TA = UA 0 1 0 TB, “0” Pulsed TB = UB 0 1 1 TA, TA2 Pulsed TA = UA, TA2 = − UA 1 0 0 TA, TA1 Pulsed TA = UA, TA1 = − UA 1 0 1 TA, TB Pulsed TA = UA, TB = − UB 1 1 0 TA, TB Pulsed TA = UA, TB = UB 1 1 1 SQ, “0” Pulsed SQ = UA - U4 and U5 comprise the “logic”′ which creates the waveform and routes the resultant signal to the output amplifiers. When the output of
U1 pin 8 is high,switch 1 of U5 is enabled, presenting the level determined by U17 to the output amplifiers, This also breaksswitch 2 of U5 which prevents contention with the output of U3. The level determined byU3 pin 8 is presented to the output amplifiers whenU1 pin 8 is low andU2 pin 8 is high. WhenU1 pin 8 andU2 pin 8 are low, corresponding to no pulses,switch 4 of U5 is enabled, thereby shorting the input of the output amplifiers to ground. This charges or resets the node to 0 VDC. - Output Amplifiers:
- The dual operation amplifier IC, U9, and associated passive components comprise the output amplifiers.
Pin 2 of U9 is a summing junction. Pulses described above induce current through R3 into the inverting node of the first amplifier (pin 2). If DC_level is set, d-c voltage appearing at the junction of R4 andU8 pin 14 induces a d-c current into the same inverting junction thereby creating a d-c voltage bias level at the output. If DC-level is not set, R4 is grounded throughswitch 2 of U8. No d-c bias appears at the output in this case. OUT is the output of the first operational amplifier. This represents the inverted pulsed signal output train. The second amplifier of U9 is also an inverter which provides a non-inverted pulse train.Switches OUT 2. A logic low selects the non-inverting output. A logic high selects the inverted output. Upon selecting the inverting output illuminates LED1. - D-C Level Circuits (
FIG. 6 ): - A 14 bit multiplying DAC, U6, operational amplifier U7, and associated passive components form the d-c level circuit. U6 is a current output DAC configured for bipolar output. -The VREF input is determined by the level of UA. Since UA ranges from 0 to +10V, the d-c level circuit can range from 0 VDC to ±10 VDC. The 14-bit DAC bus interfaces directly to P1. Three control signals LVLDAC/LDAC, LVLDAC/CS, and LVLDAC WR allow for addressing the DAC and writing levels. Refer to the AD75538 data sheet, for more detailed information on this part.
- Dual Programmable Reference:
- Referring now to
FIG. 6 , U14 is an accurate and stable +10,00 volt reference. Resistors R16 through R29 form a precision resistive divider to derive 6 other voltage levels. U10 and U11 allow for the selection of +10,00V, 5.000V, 1.000V, 0.3000V, 0.2000V, 0.1000V, 0.0100V or ground for the UA and UB channels. Signals UA_AO, UA_A1, UA_A2, UB_AO, UB_A1, and, UB_A2 determine the UA and UB reference levels respectively.TABLE 2 UA_A0 UA_A1 UA_A2 LEVEL 0 0 0 10.00 V 0 0 1 5.000 V 0 1 0 1.000 V 0 1 1 0.3000 V 1 0 0 0.2000 V 1 0 1 0.1000 V 1 1 0 0.0100 V 1 1 1 0.0000 V -
TABLE 3 UB_A0 UB_A1 UB_U2 LEVEL 0 0 0 10.00 V 0 0 1 5.000 V 0 1 0 1.000 V 0 1 1 0.3000 V 1 0 0 0.2000 V 1 0 1 0.1000 V 1 1 0 0.0100 V 1 1 1 0.0000 V - A dual op amp, U13, converts the DAC's A channel current output to +UA and −UA voltages. Likewise, U16 converts the DAC's B channel current output to +UB and −UB voltages. U12 is a dual 12-bit multiplying DAC arranged for unipolar outputs. U12 shares the same data bus per
FIGS. 5B & 6B as U6. It is addressed and controlled by the SAV_/CSA, SAV_/CSB, and SAV_/WRDAC signals. ±UA and ±UB are used by the waveform generating circuits to set signal amplitude and polarity. The UA level is also used as the reference for the level DAC. Please refer to the datasheets for the AD7538, AD7547, ADG408, ADG433, AD712,78LO5, and LT1235 components. - Voltage Output Stage:
- A ±10V voltage output is a generic output stage useful for several neuromuscular and other applications. This output stage preferably includes an output amplifier sage sufficient to drive a load. A +50V voltage output stage can be used in the alternative as a generic output stage useful for several neuromuscular and other applications. It can be limited to a lower voltage than the maximum ±50V by choosing a lower voltage power supply and changing values of appropriate components such as resistors. This higher voltage output stage is especially useful for the optimization of low voltage electroporation, and it can be packaged together with the ES component. Higher voltage output stages in the range up to 250V, or even higher up to 1,000V, or up to a few thousand volts (preferable about 6,000V), and ranges there between, can be used (or can be specially useful) for pulsed voltage electrophoresis or magnetic stimulation of the brain.
- Magnetic Sensor Probe:
- There is no good technique available on the market today to cover measurements of both time varying and constant magnetic fields in the range 01-0 Gauss, or higher (often used in biomedical experiments as well as in clinical treatment—bone healing), and those that are available do not provide a reasonable bandwidth and resolution in three directions simultaneously. Magnetoresistive sensors, such as those pioneered by Honeywell, offer the various advantages over other forms of magnetic sensors, such as flux gates or coils: small dimensions, such as needed in biomedical applications; high sensitivity, allowing for a long distance between the item being sensed and the device (dependent on its ferromagnetic mass); immunity to electromagnetic noise and interferences due to the small internal impedance; and better reliability because it is a solid state solution with no moving parts; and lower development costs because components can be easily incorporated into board-level products.
- A magnetic probe useful with the present invention is preferably a 3-axis magnetic sensor working in the range 0 to 10 Gauss, preferably 0 to 20 Gauss, or −40 Gauss, with resolution better than 100 μGauss, and diameter of approximately 1 cm. Magnetoresistive transducers are made of long strips of thin ferromagnetic films of material such as per Malloy, a nickel-iron alloy. These films are deposited and fabricated using standard semiconductor technology on silicon wafers. The strips are several hundred Angstrom (150-500) in thickness, several tens of microns wide (10-50) and several hundred to several thousand microns long, and can be used to make the magnetic probe useful for this invention. An analog output magnetic sensor hybrid (e.g., model number HMC2003, available from Honeywell) is a “building block” product that allows to use an independent micro-controller, while obtaining the resolution and sensitivity of conventional magnetoresistive technology. (The Honeywell device comes in a small 20 pin 600 mil dual-in-line package that combines the magnetic sensing components with signal conditioning electronics and amplification for each channel.) To measure the field range of 0-10 Gauss, used in some electromagnetic stimulation experiments, and preferably 0-20 Gauss, the sensor can be used in a closed mode operation. In a further embodiment, the probe includes the ability to measure temperature. Another embodiment includes a miniature 3-axis probe (<3 mm in diameter) with amplification. Both these sensors can be utilized in both ac and dc mode.
- System Overview:
- Referring again to
FIG. 1 showing the system composed ofES stage 10,output stage 11 and measuringstage 12, in using this system the user chooses the particular signal or waveform appropriate to the intended electrical stimulation application. The user uses a dial or switches attached to the system or software communicating with the system, and sets up specific timing and amplitude parameters via the serial orparallel input ports output stage 11 with either single or multiple output ports. - Measuring
stage 12, by means of asensor input terminal 12 A, allows the use of appropriate sensors to sense the electrical stimulation signal passing through the organic substance being treated and environmental parameters, such as current, magnetic field, voltage, impedance, temperature, pH, gas (O2, CO2, etc.) as well as various biochemical substances involved locally in or resulting from the procedure at the site where the signal is administered or at another site. - The various sensors for this purpose include sensing electrodes, pick-up coils, temperature-sensitive devices, magnetic probes, and biosensors, all which yield a signal which is applied to input terminal 12A this terminal is connected to a
signal conditioner 33 whose output is coupled to a measuring anddisplay unit 34 whose output is fed to a video screen or other indicator. Associated withunit 34 is adisplay control 35 and aDMM control 36. - General System Features:
- As ES system in accordance with the invention consists of a digital, high accuracy pulse generator capable of generating several either dependent or independent, synchronized rectangular pulses, available simultaneously, through a selector or preferably on a system bus. One or more output stages (identical or different) can be placed anywhere on the system bus and be accessed by a user. The choice the user makes may be threefold; either one specific output stage is plugged into the system; a specific output stage is selected among several output stages available using either a dial, a selector, or other means; or several output stages are used in parallel, either independently or triggered by each other.
- The ES system can be also triggered by an external process or event, e.g., a physiological event, and will deliver either a preset signal in response to such a stimuli, or a signal which can be continuously modified by a triggering signal with respect to both timing and amplitude (and possibly shape). A preset delay between a triggering signal and a response signal can be made available.
- Signals other than pulses can also be made available and accessible either through a selector or on the bus, including gated and/or modulated signals of various shapes. All of the signals can be fed to the output stages in the following ways: one signal to one output stage (with a single or multiple outputs); one signal to several output stages (identical or different); several signals to one output stage (for a complex signal shape or in case of multiple outputs); several signals to several output stages (identical or different).
- Several, simple or complex rectangular pulses and other signals are available, for the output stages, through a selector or preferably on the bus. These signals are synchronized and can be accessed by an output stage either by selecting only one signal or by accessing several signals at the same time. In the latter case the signals can be combined in the output stage to a more complex pattern. In either case, they can be accessed a single selected output stage or simultaneously by several, either identical or different, output stages.
- By having a number o signals accessible on the bus, output stages can have simultaneous access to identical or different signals creating the following system configurations:
-
- A. one selected output stage (either voltage—low or high, current—low or high, or power with a single output producing a simple signal; one selected output stage with a single output producing a complex signal pattern;
- B. one selected output stage with multiple identical outputs (either voltage—low or high, current—low or high, or power) with the same shape signals and identical electrical parameters; one selected output stage with multiple identical outputs with the same shape signals with different amplitudes only
- C. multiple identical output stages (either voltage—low-or high, current—low or high, or power) with the same shape signals with identical electrical parameters;
- multiple identical output stages with the same shape signals with different amplitudes;
- multiple identical output stages with the same shape signals with different timing;
- multiple identical output stages the same shape signals with different amplitude and timing;
- D. multiple identical output stages with different shape signals with all the options from above;
- E. multiple identical output stages producing signals with either identical or different complex patterns with all the options from above;
- F. multiple different output stages, e.g., a low voltage single output stage and multiple output current output stage, or a power output stage, producing the same shape signals with identical timing; multiple different output stages, producing the same shape signals with different timing; multiple different output stages, producing different shape signals with identical timing; multiple different output stages, producing different shape signals with different timing.
- While there has been shown and described preferred embodiments of a multi-functional electrical stimulation system in accordance with the invention, it will be appreciated that many changes may be made therein within the spirit of the invention.
Claims (17)
1. A multi-functional electrical stimulation system adapted to produce output signals for effecting faradic, electromagnetic and other forms of electrical stimulation for a broad spectrum of different biological and biomedical applications, said system being provided with an electrical stimulation signal stage comprising:
A. a plurality of different signal generators, each producing a signal having a distinct predetermined shape, at least on said signal generators producing pulses;
B. means associated with the generators to adjust the respective electrical parameters of the signal including the amplitude, shape and timing parameters including the duration and repetition rate of the pulses; and
C. selector means coupled to the signal generators to select as an output signal the signal yielded by the selected generator which is adjusted to be appropraite for its intended stimulation application.
2. A system as set forth in claim 1 , in which one of the generators produces a sine wave.
3. A system as set forth in claim 1 , in which one of the generators produces a square wave.
4. A system as set forth in claim 1 , in which one of the generators produces a sawtooth wave.
5. A system as set forth in claim 1 in which said means associated with the generators to adjust the electrical parameters includes a serial input port.
6. A system as set forth in claim 1 , in which said means to adjust the electrical parameters further includes parallel input ports.
7. A system as set forth in claim 1 further including at least one output stage into which is fed said output signal, the output stage processing the electrical stimulation signal to provide a signal appropriate to the application for which it is intended.
8. A system as set forth in claim 7 , in which the output stage processes the signal to yield a high or low voltage or current output.
9. A system as set forth in claim 8 , in which the output stage has multiple output terminals.
10. A system as set forth in claim 7 , further including a measuring stage adapted to measure and display the electrical stimulation signal being applied to a substance being treated as well as the outputs of various sensors which sense conditions prevailing in this substance.
11. A system as set forth in claim 10 , in which one of said sensors senses pH.
12. A system as set forth in claim 11 , in which another of said sensors senses a gas.
13. A system as set forth in claim 12 , in which the gas is oxygen.
14. A system as set forth in claim 1 , in which the generators are formed as an integrated circuit.
15. A system as set forth in claim 7 , in which the signal generators and the output stage are formed as an integrated circuit.
16. A system as set forth in claim 10 , in which the signal generators, the output stage and the measuring stage are formed as an integrated circuit.
17. A system as set forth in claim 10 , in which the outputs of said sensors which sense conditions prevailing in said substance are fed back to the system to adjust the electrical parameters of the signal so that it is appropriate for the electrical stimulation application.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/706,844 US20050216062A1 (en) | 1997-01-27 | 2003-11-12 | Multi-functional electrical stimulation system |
US11/063,195 US11865326B1 (en) | 1997-01-27 | 2005-02-22 | High precision, multi-output pulse and/or signal generators |
US11/151,967 US20060089751A1 (en) | 1997-01-27 | 2005-06-14 | Electronic delivery systems and methods with feedback |
US12/098,257 US20110230857A1 (en) | 1997-01-27 | 2008-04-04 | Electronic delivery systems and methods with feedback |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3486997P | 1997-01-27 | 1997-01-27 | |
US09/013,049 US6029090A (en) | 1997-01-27 | 1998-01-27 | Multi-functional electrical stimulation system |
US09/507,873 US6684106B2 (en) | 1997-01-27 | 2000-02-22 | Method and electronic components for multi-functional electrical stimulation systems |
US10/706,844 US20050216062A1 (en) | 1997-01-27 | 2003-11-12 | Multi-functional electrical stimulation system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/507,873 Continuation US6684106B2 (en) | 1997-01-27 | 2000-02-22 | Method and electronic components for multi-functional electrical stimulation systems |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/063,195 Continuation-In-Part US11865326B1 (en) | 1997-01-27 | 2005-02-22 | High precision, multi-output pulse and/or signal generators |
US11/151,967 Continuation-In-Part US20060089751A1 (en) | 1997-01-27 | 2005-06-14 | Electronic delivery systems and methods with feedback |
US21305005A Continuation | 1997-01-27 | 2005-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050216062A1 true US20050216062A1 (en) | 2005-09-29 |
Family
ID=26684365
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/013,049 Expired - Lifetime US6029090A (en) | 1997-01-27 | 1998-01-27 | Multi-functional electrical stimulation system |
US09/507,873 Expired - Lifetime US6684106B2 (en) | 1997-01-27 | 2000-02-22 | Method and electronic components for multi-functional electrical stimulation systems |
US10/706,844 Abandoned US20050216062A1 (en) | 1997-01-27 | 2003-11-12 | Multi-functional electrical stimulation system |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/013,049 Expired - Lifetime US6029090A (en) | 1997-01-27 | 1998-01-27 | Multi-functional electrical stimulation system |
US09/507,873 Expired - Lifetime US6684106B2 (en) | 1997-01-27 | 2000-02-22 | Method and electronic components for multi-functional electrical stimulation systems |
Country Status (3)
Country | Link |
---|---|
US (3) | US6029090A (en) |
AU (1) | AU2350799A (en) |
WO (1) | WO1999037359A1 (en) |
Cited By (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060253174A1 (en) * | 2005-04-30 | 2006-11-09 | Medtronic, Inc. | Impedance-based stimulation adjustment |
US20070106337A1 (en) * | 2005-11-10 | 2007-05-10 | Electrocore, Inc. | Methods And Apparatus For Treating Disorders Through Neurological And/Or Muscular Intervention |
US20070106338A1 (en) * | 2005-11-10 | 2007-05-10 | Electrocore, Inc. | Direct and Indirect Control of Muscle for the Treatment of Pathologies |
US20070173712A1 (en) * | 2005-12-30 | 2007-07-26 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US20070239696A1 (en) * | 2006-03-28 | 2007-10-11 | Microsoft Corporation | Interactive relational graphic solutions |
WO2007121424A2 (en) | 2006-04-18 | 2007-10-25 | Electrocore, Inc. | Methods and apparatus for treating ileus condition using electrical signals |
US20090259274A1 (en) * | 2008-04-10 | 2009-10-15 | Electrocore, Inc. | Methods And Apparatus For Electrical Treatment Using Balloon And Electrode |
US7711430B2 (en) | 2006-02-10 | 2010-05-04 | Electrocore Llc | Methods and apparatus for treating anaphylaxis using electrical modulation |
US7725188B2 (en) | 2006-02-10 | 2010-05-25 | Electrocore Llc | Electrical stimulation treatment of hypotension |
US20100160996A1 (en) * | 2008-12-18 | 2010-06-24 | Electrocore, Inc. | Methods and apparatus for electrical stimulation treatment using esophageal balloon and electrode |
US7747324B2 (en) | 2005-11-10 | 2010-06-29 | Electrocore Llc | Electrical stimulation treatment of bronchial constriction |
US20110152967A1 (en) * | 2009-03-20 | 2011-06-23 | ElectroCore, LLC. | Non-invasive treatment of neurodegenerative diseases |
US20110230938A1 (en) * | 2009-03-20 | 2011-09-22 | ElectroCore, LLC. | Device and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation |
US8041428B2 (en) | 2006-02-10 | 2011-10-18 | Electrocore Llc | Electrical stimulation treatment of hypotension |
WO2012024169A2 (en) | 2010-08-19 | 2012-02-23 | Electrocore Llc | Non-invasive treatment of bronchial constriction |
US8483839B2 (en) | 2005-04-28 | 2013-07-09 | Medtronic, Inc. | Activity sensing for stimulator control |
US8682449B2 (en) | 2008-04-10 | 2014-03-25 | ElectroCore, LLC | Methods and apparatus for transcranial stimulation |
US8812112B2 (en) | 2005-11-10 | 2014-08-19 | ElectroCore, LLC | Electrical treatment of bronchial constriction |
EP2962725A1 (en) | 2011-03-10 | 2016-01-06 | Electrocore LLC | Apparatus for nerve modulation |
US9360447B2 (en) | 2005-12-30 | 2016-06-07 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
US9610444B2 (en) | 2013-03-15 | 2017-04-04 | Pacesetter, Inc. | Erythropoeitin production by electrical stimulation |
US10173048B2 (en) | 2011-03-10 | 2019-01-08 | Electrocore, Inc. | Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders |
US10207106B2 (en) | 2009-03-20 | 2019-02-19 | ElectroCore, LLC | Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders |
US10213601B2 (en) | 2005-11-10 | 2019-02-26 | Electrocore, Inc. | Non-invasive vagus nerve stimulation devices and methods to treat or avert atrial fibrillation |
US10220207B2 (en) | 2009-03-20 | 2019-03-05 | Electrocore, Inc. | Nerve stimulation methods for averting imminent onset or episode of a disease |
US10232178B2 (en) | 2009-03-20 | 2019-03-19 | Electrocore, Inc. | Non-invasive magnetic or electrical nerve stimulation to treat or prevent dementia |
US10232174B2 (en) | 2009-03-20 | 2019-03-19 | Electrocore, Inc. | Non-invasive electrical and magnetic nerve stimulators used to treat overactive bladder and urinary incontinence |
US10232177B2 (en) | 2013-01-15 | 2019-03-19 | ElectroCore, LLC | Mobile phone using non-invasive nerve stimulation |
US10252074B2 (en) | 2009-03-20 | 2019-04-09 | ElectroCore, LLC | Nerve stimulation methods for averting imminent onset or episode of a disease |
US10286211B2 (en) | 2011-08-31 | 2019-05-14 | Electrocore, Inc. | Systems and methods for vagal nerve stimulation |
US10286212B2 (en) | 2009-03-20 | 2019-05-14 | Electrocore, Inc. | Nerve stimulation methods for averting imminent onset or episode of a disease |
US10293160B2 (en) | 2013-01-15 | 2019-05-21 | Electrocore, Inc. | Mobile phone for treating a patient with dementia |
WO2019123395A1 (en) * | 2017-12-20 | 2019-06-27 | Panacea Quantum Leap Technology Llc | Tissue-stimulation device with output demultiplexer |
US10335593B2 (en) | 2009-03-20 | 2019-07-02 | Electrocore, Inc. | Devices and methods for monitoring non-invasive vagus nerve stimulation |
US10350411B2 (en) | 2013-04-28 | 2019-07-16 | Electrocore, Inc. | Devices and methods for treating medical disorders with evoked potentials and vagus nerve stimulation |
US10363415B2 (en) | 2010-08-19 | 2019-07-30 | Electrocore, Inc. | Devices and methods for non-invasive electrical stimulation and their use for Vagal nerve stimulation |
US10363419B2 (en) | 2013-11-04 | 2019-07-30 | Electrocore, Inc. | Nerve stimulator system |
US10376696B2 (en) | 2009-03-20 | 2019-08-13 | Electrocore, Inc. | Medical self-treatment using non-invasive vagus nerve stimulation |
US10384059B2 (en) | 2011-03-10 | 2019-08-20 | Electrocore, Inc. | Non-invasive vagal nerve stimulation to treat disorders |
US10384061B2 (en) | 2005-11-10 | 2019-08-20 | Electrocore, Inc. | Methods and devices for treating primary headache |
US10441780B2 (en) | 2005-11-10 | 2019-10-15 | Electrocore, Inc. | Systems and methods for vagal nerve stimulation |
US10507325B2 (en) | 2009-03-20 | 2019-12-17 | Electrocore, Inc. | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
US10512769B2 (en) | 2009-03-20 | 2019-12-24 | Electrocore, Inc. | Non-invasive magnetic or electrical nerve stimulation to treat or prevent autism spectrum disorders and other disorders of psychological development |
US10537728B2 (en) | 2005-11-10 | 2020-01-21 | ElectroCore, LLC | Vagal nerve stimulation to avert or treat stroke or transient ischemic attack |
EP3854450A1 (en) | 2012-09-05 | 2021-07-28 | electroCore, Inc. | Non-invasive vagal nerve stimulation to treat disorders |
US11185690B2 (en) | 2016-05-23 | 2021-11-30 | BTL Healthcare Technologies, a.s. | Systems and methods for tissue treatment |
WO2021243247A1 (en) * | 2020-05-28 | 2021-12-02 | Musc Foundation For Research Development | Noninvasive cranial nerve therapy |
US11191953B2 (en) | 2010-08-19 | 2021-12-07 | Electrocore, Inc. | Systems and methods for vagal nerve stimulation |
US11229790B2 (en) | 2013-01-15 | 2022-01-25 | Electrocore, Inc. | Mobile phone for treating a patient with seizures |
US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US11247063B2 (en) | 2019-04-11 | 2022-02-15 | Btl Healthcare Technologies A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11253718B2 (en) | 2015-07-01 | 2022-02-22 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
US11266852B2 (en) | 2016-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11297445B2 (en) | 2005-11-10 | 2022-04-05 | Electrocore, Inc. | Methods and devices for treating primary headache |
US11351363B2 (en) | 2005-11-10 | 2022-06-07 | Electrocore, Inc. | Nerve stimulation devices and methods for treating cardiac arrhythmias |
US11400288B2 (en) | 2010-08-19 | 2022-08-02 | Electrocore, Inc | Devices and methods for electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
US11424755B2 (en) | 2019-10-11 | 2022-08-23 | Regents Of The University Of Minnesota | System and method for a super-resolution digital-to-analog converter based on redundant sensing |
US11432760B2 (en) | 2011-01-12 | 2022-09-06 | Electrocore, Inc. | Devices and methods for remote therapy and patient monitoring |
US11439818B2 (en) | 2011-03-10 | 2022-09-13 | Electrocore, Inc. | Electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders |
US11458297B2 (en) | 2011-03-10 | 2022-10-04 | Electrocore, Inc | Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders |
US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US11464994B2 (en) | 2016-05-10 | 2022-10-11 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11484727B2 (en) | 2016-07-01 | 2022-11-01 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11612758B2 (en) | 2012-07-05 | 2023-03-28 | Btl Medical Solutions A.S. | Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields |
US11806528B2 (en) | 2020-05-04 | 2023-11-07 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
US11826565B2 (en) | 2020-05-04 | 2023-11-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
US11865329B2 (en) | 2010-08-19 | 2024-01-09 | Electrocore, Inc. | Vagal nerve stimulation for treating post-traumatic stress disorder |
US11865326B1 (en) * | 1997-01-27 | 2024-01-09 | Innovations Holdings, L.L.C. | High precision, multi-output pulse and/or signal generators |
US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
Families Citing this family (183)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6029090A (en) * | 1997-01-27 | 2000-02-22 | Herbst; Ewa | Multi-functional electrical stimulation system |
US6708066B2 (en) * | 1999-12-10 | 2004-03-16 | Ewa Herbst | Electrochemical treatment of tissues, especially tumors |
DE19823047C1 (en) * | 1998-05-22 | 1999-08-26 | Fuhr | Electro-manipulation of cells for permeation and fusion reduces stress on cells due to pH fluctuations |
JP3385506B2 (en) * | 1998-10-22 | 2003-03-10 | 址岩 相崎 | DC AC potential therapy device |
US7620527B1 (en) | 1999-05-10 | 2009-11-17 | Johan Leo Alfons Gielis | Method and apparatus for synthesizing and analyzing patterns utilizing novel “super-formula” operator |
US6445955B1 (en) * | 1999-07-08 | 2002-09-03 | Stephen A. Michelson | Miniature wireless transcutaneous electrical neuro or muscular-stimulation unit |
US6850871B1 (en) * | 1999-10-18 | 2005-02-01 | Agilent Technologies, Inc. | Method and apparatus for extraction of nonlinear black-box behavioral models from embeddings of the time-domain measurements |
US6445171B2 (en) | 1999-10-29 | 2002-09-03 | Honeywell Inc. | Closed-loop magnetoresistive current sensor system having active offset nulling |
US6775646B1 (en) | 2000-02-23 | 2004-08-10 | Agilent Technologies, Inc. | Excitation signal and radial basis function methods for use in extraction of nonlinear black-box behavioral models |
US6393328B1 (en) * | 2000-05-08 | 2002-05-21 | International Rehabilitative Sciences, Inc. | Multi-functional portable electro-medical device |
SE516707C2 (en) * | 2000-05-30 | 2002-02-19 | Volvo Lastvagnar Ab | Power units for motor vehicles |
IT1319170B1 (en) | 2000-07-28 | 2003-09-26 | Lorenzo Piccone | APPARATUS ABLE TO MODULATE THE NEUROVEGETATIVE SYSTEM AND INTEGRATE ITS ACTION WITH THAT OF THE CENTRAL NERVOUS SYSTEM: |
US8251986B2 (en) * | 2000-08-17 | 2012-08-28 | Angiodynamics, Inc. | Method of destroying tissue cells by eletroporation |
WO2002054404A1 (en) * | 2000-12-28 | 2002-07-11 | Sony Corporation | Data transmission system, data transmission method, and electronic apparatus |
EP1224950A1 (en) * | 2001-01-19 | 2002-07-24 | James Lee Hedgecock | Stair step current CPT measurement method and apparatus |
EP1224951B1 (en) | 2001-01-19 | 2006-11-08 | James Lee Hedgecock | Stair step voltage actuated measurement apparatus |
AU2002245675A1 (en) * | 2001-03-13 | 2002-09-24 | University Of South Florida | Electromanipulation device and method |
US6572528B2 (en) * | 2001-04-20 | 2003-06-03 | Mclean Hospital Corporation | Magnetic field stimulation techniques |
US8047979B2 (en) | 2001-04-20 | 2011-11-01 | Mclean Hospital Corporation | Magnetic field treatment techniques |
AT411150B (en) * | 2001-05-25 | 2003-10-27 | Nova Technical Res Gmbh | DEVICE FOR INTRODUCING SUBSTANCES |
AU2002320145A1 (en) * | 2001-06-21 | 2003-01-08 | Vanderbilt University | Method for promoting reinnervation of denervated tissue |
US6760675B1 (en) * | 2001-07-19 | 2004-07-06 | Itt Manufacturing Enterprises, Inc. | Adjustable high current and high voltage pulse generator |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US20030158585A1 (en) * | 2002-02-19 | 2003-08-21 | Burnett Daniel R. | Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues |
US6701185B2 (en) | 2002-02-19 | 2004-03-02 | Daniel Burnett | Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues |
US6745078B1 (en) * | 2002-04-24 | 2004-06-01 | Kelly W. Buchner | Procedure and machine for electro-inducing/stimulating deep-layered muscle contractions using a biphasic faradic pulse sequence |
US7147647B2 (en) * | 2002-04-26 | 2006-12-12 | Medtronic, Inc. | Sintered titanium tube for the management of spinal cord injury |
US6830550B2 (en) | 2002-06-25 | 2004-12-14 | James Lee Hedgecock | Stair step voltage actuated measurement method and apparatus |
US6739180B2 (en) * | 2002-08-30 | 2004-05-25 | Industrial Technology Research Institute | Intelligent gas identification system and method thereof |
US20040098065A1 (en) * | 2002-11-19 | 2004-05-20 | Alliance Health Products, Llc | Transcutaneous nerve and muscle stimulator and method of using the same |
ITMO20030019A1 (en) * | 2003-01-28 | 2004-07-29 | Lorenz Biotech Spa | APPARATUS AND METHOD OF ELECTROSTIMULATION AND RELATED DATA SUPPORT. |
TW200416015A (en) * | 2003-02-17 | 2004-09-01 | Wei-Gung Wang | Device for selectively generating hydrogen ions in an aqueous solution |
ATE444777T1 (en) * | 2003-06-06 | 2009-10-15 | Telea Electronic Eng Srl | COSMETIC PROCEDURE FOR TREATING SKIN AGING |
US7783353B2 (en) | 2003-12-24 | 2010-08-24 | Cardiac Pacemakers, Inc. | Automatic neural stimulation modulation based on activity and circadian rhythm |
US7212865B2 (en) * | 2004-05-25 | 2007-05-01 | Philip Cory | Nerve stimulator and method |
WO2005117696A2 (en) * | 2004-05-27 | 2005-12-15 | Parker Richard F | Method and apparatus for generating a therapeutic magnetic field |
WO2005122740A2 (en) * | 2004-06-15 | 2005-12-29 | Compex Technologies, Inc. | Interferential and neuromuscular electrical stimulation system and apparatus |
US7346382B2 (en) | 2004-07-07 | 2008-03-18 | The Cleveland Clinic Foundation | Brain stimulation models, systems, devices, and methods |
US7662615B2 (en) * | 2004-07-27 | 2010-02-16 | Chung Yuan Christian University | System and method for cultivating cells |
US20060052846A1 (en) * | 2004-09-08 | 2006-03-09 | Chieh-Lin Liu | Physical electrotherapy device |
US10201305B2 (en) * | 2004-11-02 | 2019-02-12 | Medtronic, Inc. | Apparatus for data retention in an implantable medical device |
US8768446B2 (en) * | 2004-11-02 | 2014-07-01 | Medtronic, Inc. | Clustering with combined physiological signals |
US8024029B2 (en) * | 2004-11-02 | 2011-09-20 | Medtronic, Inc. | Techniques for user-activated data retention in an implantable medical device |
US7917199B2 (en) * | 2004-11-02 | 2011-03-29 | Medtronic, Inc. | Patient event marking in combination with physiological signals |
US8140165B2 (en) | 2005-01-28 | 2012-03-20 | Encore Medical Asset Corporation | Independent protection system for an electrical muscle stimulation apparatus and method of using same |
US20060194724A1 (en) * | 2005-02-25 | 2006-08-31 | Whitehurst Todd K | Methods and systems for nerve regeneration |
US8112154B2 (en) * | 2005-04-13 | 2012-02-07 | The Cleveland Clinic Foundation | Systems and methods for neuromodulation using pre-recorded waveforms |
US9339650B2 (en) | 2005-04-13 | 2016-05-17 | The Cleveland Clinic Foundation | Systems and methods for neuromodulation using pre-recorded waveforms |
ES2561581T3 (en) | 2005-04-19 | 2016-02-29 | Compex Technologies, Inc. | Electrical stimulation device |
US7840272B2 (en) | 2005-06-03 | 2010-11-23 | Medrelief Inc. | Methods for modulating osteochondral development using bioelectrical stimulation |
WO2007019491A2 (en) * | 2005-08-08 | 2007-02-15 | Katims Jefferson J | Method and apparatus for producing therapeutic and diagnostic stimulation |
US7419474B2 (en) * | 2006-01-03 | 2008-09-02 | Richard Lee | Non-linear therapy signal synthesizer |
US9610459B2 (en) * | 2009-07-24 | 2017-04-04 | Emkinetics, Inc. | Cooling systems and methods for conductive coils |
US20070167990A1 (en) * | 2006-01-17 | 2007-07-19 | Theranova, Llc | Method and apparatus for low frequency induction therapy for the treatment of urinary incontinence and overactive bladder |
US9339641B2 (en) | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US20100168501A1 (en) * | 2006-10-02 | 2010-07-01 | Daniel Rogers Burnett | Method and apparatus for magnetic induction therapy |
US8005633B2 (en) * | 2006-02-06 | 2011-08-23 | Verigy (Singapore) Pte. Ltd. | Excitation signal generator for improved accuracy of model-based testing |
US7881804B2 (en) * | 2006-03-15 | 2011-02-01 | Kenergy, Inc. | Composite waveform based method and apparatus for animal tissue stimulation |
US20070232984A1 (en) * | 2006-03-30 | 2007-10-04 | Michael Lovell | Hand-held electrical stimulation device |
US7986506B2 (en) | 2006-05-03 | 2011-07-26 | Taser International, Inc. | Systems and methods for arc energy regulation and pulse delivery |
US20090077877A1 (en) * | 2006-08-08 | 2009-03-26 | Richard Kerber | Method and apparatus for precluding plant trunks from freezing |
US20080039904A1 (en) * | 2006-08-08 | 2008-02-14 | Cherik Bulkes | Intravascular implant system |
US10786669B2 (en) | 2006-10-02 | 2020-09-29 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US9005102B2 (en) | 2006-10-02 | 2015-04-14 | Emkinetics, Inc. | Method and apparatus for electrical stimulation therapy |
US11224742B2 (en) | 2006-10-02 | 2022-01-18 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
WO2008042902A2 (en) * | 2006-10-02 | 2008-04-10 | Emkinetics, Inc. | Method and apparatus for magnetic induction therapy |
US8620438B1 (en) | 2007-02-13 | 2013-12-31 | Encore Medical Asset Corporation | Method and apparatus for applying neuromuscular electrical stimulation |
WO2008137452A1 (en) * | 2007-05-04 | 2008-11-13 | Kenergy Royalty Company, Llc | Implantable high efficiency digital stimulation device |
CN101743035B (en) * | 2007-05-21 | 2014-04-23 | 盖布利叶拉·罗慕斯·里尔 | Low-frequency electrostimulating apparatus for prevention and curing of chronic wounds |
US7769463B2 (en) | 2007-06-19 | 2010-08-03 | Kalaco Scientific, Inc. | Multi-channel electrostimulation apparatus and method |
CA2694498C (en) | 2007-07-20 | 2014-12-02 | Boston Scientific Neuromodulation Corporation | Use of stimulation pulse shape to control neural recruitment order and clinical effect |
US20130304152A1 (en) * | 2012-05-14 | 2013-11-14 | Boston Scientific Neuromodulation Corporation | System and method for shaped phased current delivery |
US11376435B2 (en) | 2007-07-20 | 2022-07-05 | Boston Scientific Neuromodulation Corporation | System and method for shaped phased current delivery |
US8260425B2 (en) | 2007-10-12 | 2012-09-04 | Intelect Medical, Inc. | Deep brain stimulation system with inputs |
US8812123B2 (en) * | 2007-10-17 | 2014-08-19 | Intelect Medical, Inc. | Patient programmer with input and sensing capabilities |
US9220889B2 (en) | 2008-02-11 | 2015-12-29 | Intelect Medical, Inc. | Directional electrode devices with locating features |
US8019440B2 (en) | 2008-02-12 | 2011-09-13 | Intelect Medical, Inc. | Directional lead assembly |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
AU2009243079A1 (en) * | 2008-04-29 | 2009-11-05 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation to create tissue scaffolds |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US9283051B2 (en) | 2008-04-29 | 2016-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10448989B2 (en) | 2009-04-09 | 2019-10-22 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US9272153B2 (en) | 2008-05-15 | 2016-03-01 | Boston Scientific Neuromodulation Corporation | VOA generation system and method using a fiber specific analysis |
CN101334456B (en) * | 2008-06-30 | 2012-07-25 | 东软飞利浦医疗设备系统有限责任公司 | Magnetic nuclear resonance radio frequency receiving signal digital downward conversion implementing device and method |
US8285381B2 (en) * | 2008-07-02 | 2012-10-09 | Niveus Medical, Inc. | Systems and methods for automated muscle stimulation |
US8892210B2 (en) | 2008-07-02 | 2014-11-18 | Niveus Medical, Inc. | Devices, systems, and methods for automated optimization of energy delivery |
US8868204B2 (en) * | 2008-07-15 | 2014-10-21 | Venus Technologies LTD. | Esthetic device useful for increasing skin beautification and methods thereof |
US8265763B2 (en) * | 2008-08-26 | 2012-09-11 | Niveus Medical, Inc. | Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema |
US9149386B2 (en) | 2008-08-19 | 2015-10-06 | Niveus Medical, Inc. | Devices and systems for stimulation of tissues |
AU2010215784B2 (en) * | 2009-02-20 | 2015-04-30 | Sage Products, Llc | Systems and methods of powered muscle stimulation using an energy guidance field |
EP2221086A1 (en) | 2009-02-24 | 2010-08-25 | Enrico Spugnini | Portable equipment comprising generator circuit and provider for therapeutic transfer of molecules by electroporation |
WO2010118387A1 (en) | 2009-04-09 | 2010-10-14 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
US8903488B2 (en) | 2009-05-28 | 2014-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
CA2772330A1 (en) | 2009-08-27 | 2011-03-03 | The Cleveland Clinic Foundation | System and method to estimate region of tissue activation |
JP2013508119A (en) | 2009-10-26 | 2013-03-07 | エムキネティクス, インコーポレイテッド | Method and apparatus for electromagnetic stimulation of nerves, muscles and body tissues |
WO2011060056A2 (en) | 2009-11-11 | 2011-05-19 | Niveus Mediacl, Inc. | Synergistic muscle activation device |
WO2011068997A1 (en) | 2009-12-02 | 2011-06-09 | The Cleveland Clinic Foundation | Reversing cognitive-motor impairments in patients having a neuro-degenerative disease using a computational modeling approach to deep brain stimulation programming |
US8588884B2 (en) | 2010-05-28 | 2013-11-19 | Emkinetics, Inc. | Microneedle electrode |
JP5778263B2 (en) | 2010-06-04 | 2015-09-16 | ユニヴァーシティ・ヘルス・ネットワーク | Functional electrical stimulator and system and use thereof |
JP5830090B2 (en) | 2010-06-14 | 2015-12-09 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Programming interface for spinal nerve regulation |
WO2012003451A2 (en) | 2010-07-01 | 2012-01-05 | Stimdesigns Llc | Universal closed-loop electrical stimulation system |
US9700368B2 (en) | 2010-10-13 | 2017-07-11 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US9166321B2 (en) | 2011-03-22 | 2015-10-20 | Greatbatch Ltd. | Thin profile stacked layer contact |
US9063643B2 (en) | 2011-03-29 | 2015-06-23 | Boston Scientific Neuromodulation Corporation | System and method for leadwire location |
US8996117B2 (en) | 2011-04-07 | 2015-03-31 | Greatbatch, Ltd. | Arbitrary waveform generator and neural stimulation application with scalable waveform feature |
US8874219B2 (en) | 2011-04-07 | 2014-10-28 | Greatbatch, Ltd. | Arbitrary waveform generator and neural stimulation application |
US9656076B2 (en) | 2011-04-07 | 2017-05-23 | Nuvectra Corporation | Arbitrary waveform generator and neural stimulation application with scalable waveform feature and charge balancing |
US8996115B2 (en) | 2011-04-07 | 2015-03-31 | Greatbatch, Ltd. | Charge balancing for arbitrary waveform generator and neural stimulation application |
US9592389B2 (en) | 2011-05-27 | 2017-03-14 | Boston Scientific Neuromodulation Corporation | Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information |
EP2742448A1 (en) | 2011-08-09 | 2014-06-18 | Boston Scientific Neuromodulation Corporation | Remote control for blind clinical trials of electrical stimulation |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
GB201203018D0 (en) * | 2012-02-22 | 2012-04-04 | Nordic Semiconductor Asa | Input controller |
EP2819745B1 (en) | 2012-02-29 | 2018-10-10 | The Cleveland Clinic Foundation | System and method for generating composite patterns of stimulation or waveforms |
EP2879757B1 (en) | 2012-08-04 | 2019-06-26 | Boston Scientific Neuromodulation Corporation | Systems and methods for storing and transferring registration, atlas, and lead information between medical devices |
AU2013308906B2 (en) | 2012-08-28 | 2016-07-21 | Boston Scientific Neuromodulation Corporation | Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines |
US9782587B2 (en) | 2012-10-01 | 2017-10-10 | Nuvectra Corporation | Digital control for pulse generators |
JP5580383B2 (en) * | 2012-10-05 | 2014-08-27 | 株式会社 資生堂 | Beauty device, energization method and recording medium |
US9792412B2 (en) | 2012-11-01 | 2017-10-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for VOA model generation and use |
US9174053B2 (en) | 2013-03-08 | 2015-11-03 | Boston Scientific Neuromodulation Corporation | Neuromodulation using modulated pulse train |
US10098585B2 (en) | 2013-03-15 | 2018-10-16 | Cadwell Laboratories, Inc. | Neuromonitoring systems and methods |
US20160296752A1 (en) * | 2013-03-15 | 2016-10-13 | Nes Health, Ltd. | Pulse polarity switching for improved human body stimulation and healing |
US11219757B2 (en) * | 2013-10-08 | 2022-01-11 | University Of Guelph | Ischemic training apparatus and method |
US10154873B2 (en) | 2013-11-14 | 2018-12-18 | Rm2 Technology Llc | Methods, systems, and apparatuses for delivery of electrolysis products |
CN103885417B (en) * | 2014-03-24 | 2017-03-08 | 上海航天电子通讯设备研究所 | A kind of alternating current-direct current hybrid pumping signal dispensing device based on pci bus |
US9364667B1 (en) | 2014-03-31 | 2016-06-14 | Elassia LLC | Potentiating or eliciting an erotic sensation in a body using electrostimulation |
US10471254B2 (en) | 2014-05-12 | 2019-11-12 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
CA2953578C (en) | 2014-07-03 | 2019-01-08 | Boston Scientific Neuromodulation Corporation | Neurostimulation system with flexible patterning and waveforms |
US9959388B2 (en) | 2014-07-24 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for providing electrical stimulation therapy feedback |
US10265528B2 (en) | 2014-07-30 | 2019-04-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrical stimulation-related patient population volume analysis and use |
US10272247B2 (en) | 2014-07-30 | 2019-04-30 | Boston Scientific Neuromodulation Corporation | Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming |
US9918669B2 (en) | 2014-08-08 | 2018-03-20 | Medtronic Xomed, Inc. | Wireless nerve integrity monitoring systems and devices |
WO2016053375A1 (en) | 2014-10-01 | 2016-04-07 | James Phillips | System and method for transcranial current loop brain stimulation |
WO2016057544A1 (en) | 2014-10-07 | 2016-04-14 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
WO2016100325A1 (en) | 2014-12-15 | 2016-06-23 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US20160287112A1 (en) * | 2015-04-03 | 2016-10-06 | Medtronic Xomed, Inc. | System And Method For Omni-Directional Bipolar Stimulation Of Nerve Tissue Of A Patient Via A Bipolar Stimulation Probe |
US10039915B2 (en) | 2015-04-03 | 2018-08-07 | Medtronic Xomed, Inc. | System and method for omni-directional bipolar stimulation of nerve tissue of a patient via a surgical tool |
WO2016178697A1 (en) | 2015-05-01 | 2016-11-10 | Inter Science Gmbh | Methods, systems, and apparatuses for tissue ablation using pulse shape designs |
US9956419B2 (en) | 2015-05-26 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
US10780283B2 (en) | 2015-05-26 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
US9827422B2 (en) | 2015-05-28 | 2017-11-28 | Boston Scientific Neuromodulation Corporation | Neuromodulation using stochastically-modulated stimulation parameters |
EP3280491B1 (en) | 2015-06-29 | 2023-03-01 | Boston Scientific Neuromodulation Corporation | Systems for selecting stimulation parameters by targeting and steering |
EP3280490B1 (en) | 2015-06-29 | 2021-09-01 | Boston Scientific Neuromodulation Corporation | Systems for selecting stimulation parameters based on stimulation target region, effects, or side effects |
WO2017062378A1 (en) | 2015-10-09 | 2017-04-13 | Boston Scientific Neuromodulation Corporation | System and methods for clinical effects mapping for directional stimulations leads |
US10339273B2 (en) | 2015-11-18 | 2019-07-02 | Warsaw Orthopedic, Inc. | Systems and methods for pre-operative procedure determination and outcome predicting |
US10445466B2 (en) | 2015-11-18 | 2019-10-15 | Warsaw Orthopedic, Inc. | Systems and methods for post-operative outcome monitoring |
US10716942B2 (en) | 2016-04-25 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | System and methods for directional steering of electrical stimulation |
WO2017223505A2 (en) | 2016-06-24 | 2017-12-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for visual analytics of clinical effects |
WO2018044881A1 (en) | 2016-09-02 | 2018-03-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
US10849517B2 (en) | 2016-09-19 | 2020-12-01 | Medtronic Xomed, Inc. | Remote control module for instruments |
US10780282B2 (en) | 2016-09-20 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters |
CN109803719B (en) | 2016-10-14 | 2023-05-26 | 波士顿科学神经调制公司 | System and method for closed loop determination of stimulation parameter settings for an electrical simulation system |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
AU2017391436B2 (en) | 2017-01-03 | 2020-06-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting MRI-compatible stimulation parameters |
US10589104B2 (en) | 2017-01-10 | 2020-03-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for creating stimulation programs based on user-defined areas or volumes |
US9935395B1 (en) | 2017-01-23 | 2018-04-03 | Cadwell Laboratories, Inc. | Mass connection plate for electrical connectors |
US10569081B2 (en) * | 2017-03-03 | 2020-02-25 | Medtronic, Inc. | Stacked potential electroporation |
US10625082B2 (en) | 2017-03-15 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Visualization of deep brain stimulation efficacy |
WO2018187090A1 (en) | 2017-04-03 | 2018-10-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
AU2018301355B2 (en) | 2017-07-14 | 2020-10-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating clinical effects of electrical stimulation |
WO2019036180A1 (en) | 2017-08-15 | 2019-02-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
WO2019210214A1 (en) | 2018-04-27 | 2019-10-31 | Boston Scientific Neuromodulation Corporation | Systems for visualizing and programming electrical stimulation |
US11298553B2 (en) | 2018-04-27 | 2022-04-12 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
US11253182B2 (en) | 2018-05-04 | 2022-02-22 | Cadwell Laboratories, Inc. | Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation |
US11443649B2 (en) | 2018-06-29 | 2022-09-13 | Cadwell Laboratories, Inc. | Neurophysiological monitoring training simulator |
WO2020010388A1 (en) * | 2018-07-13 | 2020-01-16 | International Scientific Pty Ltd | A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients |
EP3846724A4 (en) * | 2018-09-04 | 2022-05-11 | Inter Science GmbH | Methods, systems, and apparatuses for tissue ablation using a modulated exponential decay pulse |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
CA3084780A1 (en) * | 2020-06-24 | 2021-12-24 | Rodney HERRING | Use of low iron oxide iron-doped titanium dioxide nanoparticles in the treatment of tumors and other diseases |
WO2022015707A1 (en) * | 2020-07-13 | 2022-01-20 | EPIC Neuro, Inc. | Brain stimulation using subcranial electrode and subcutaneous electrode |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3294092A (en) * | 1965-09-13 | 1966-12-27 | Fred S Landauer | Therapeutic apparatus |
US4503863A (en) * | 1979-06-29 | 1985-03-12 | Katims Jefferson J | Method and apparatus for transcutaneous electrical stimulation |
US4926865A (en) * | 1987-10-01 | 1990-05-22 | Oman Paul S | Microcomputer-based nerve and muscle stimulator |
US4895154A (en) * | 1988-02-19 | 1990-01-23 | Staodynamics, Inc. | Electronic stimulating device for enhanced healing of soft tissue wounds |
US5329931A (en) * | 1989-02-21 | 1994-07-19 | William L. Clauson | Apparatus and method for automatic stimulation of mammals in response to blood gas analysis |
JPH02265571A (en) * | 1989-04-07 | 1990-10-30 | Omron Tateisi Electron Co | Low frequency remedial equipment |
US5755745A (en) | 1995-09-29 | 1998-05-26 | International Rehabilitative Sciences, Inc. | Portable muscle stimulator with removable data storage card |
US6029090A (en) * | 1997-01-27 | 2000-02-22 | Herbst; Ewa | Multi-functional electrical stimulation system |
US6393328B1 (en) | 2000-05-08 | 2002-05-21 | International Rehabilitative Sciences, Inc. | Multi-functional portable electro-medical device |
-
1998
- 1998-01-27 US US09/013,049 patent/US6029090A/en not_active Expired - Lifetime
-
1999
- 1999-01-25 WO PCT/US1999/002036 patent/WO1999037359A1/en active Application Filing
- 1999-01-25 AU AU23507/99A patent/AU2350799A/en not_active Abandoned
-
2000
- 2000-02-22 US US09/507,873 patent/US6684106B2/en not_active Expired - Lifetime
-
2003
- 2003-11-12 US US10/706,844 patent/US20050216062A1/en not_active Abandoned
Cited By (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11865326B1 (en) * | 1997-01-27 | 2024-01-09 | Innovations Holdings, L.L.C. | High precision, multi-output pulse and/or signal generators |
US8483839B2 (en) | 2005-04-28 | 2013-07-09 | Medtronic, Inc. | Activity sensing for stimulator control |
US8831737B2 (en) | 2005-04-28 | 2014-09-09 | Medtronic, Inc. | Activity sensing for stimulator control |
US7720548B2 (en) | 2005-04-30 | 2010-05-18 | Medtronic | Impedance-based stimulation adjustment |
US20060259079A1 (en) * | 2005-04-30 | 2006-11-16 | Medtronic, Inc. | Impedance-based stimulation adjustment |
US8121702B2 (en) | 2005-04-30 | 2012-02-21 | Medtronic, Inc. | Impedance-based stimulation adjustment |
US8108049B2 (en) | 2005-04-30 | 2012-01-31 | Medtronic, Inc. | Impedance-based stimulation adjustment |
US8825175B2 (en) | 2005-04-30 | 2014-09-02 | Medtronic, Inc. | Impedance-based stimulation adjustment |
US20060253174A1 (en) * | 2005-04-30 | 2006-11-09 | Medtronic, Inc. | Impedance-based stimulation adjustment |
US20100161007A1 (en) * | 2005-04-30 | 2010-06-24 | Medtronic, Inc. | Impedance-based stimulation adjustment |
US10384061B2 (en) | 2005-11-10 | 2019-08-20 | Electrocore, Inc. | Methods and devices for treating primary headache |
US10537728B2 (en) | 2005-11-10 | 2020-01-21 | ElectroCore, LLC | Vagal nerve stimulation to avert or treat stroke or transient ischemic attack |
US8840537B2 (en) | 2005-11-10 | 2014-09-23 | ElectroCore, LLC | Non-invasive treatment of bronchial constriction |
US11179560B2 (en) | 2005-11-10 | 2021-11-23 | Electrocore, Inc. | Non-invasive vagus nerve stimulation devices and methods to treat or avert atrial fibrillation |
US7747324B2 (en) | 2005-11-10 | 2010-06-29 | Electrocore Llc | Electrical stimulation treatment of bronchial constriction |
US11351363B2 (en) | 2005-11-10 | 2022-06-07 | Electrocore, Inc. | Nerve stimulation devices and methods for treating cardiac arrhythmias |
US9037247B2 (en) | 2005-11-10 | 2015-05-19 | ElectroCore, LLC | Non-invasive treatment of bronchial constriction |
US11297445B2 (en) | 2005-11-10 | 2022-04-05 | Electrocore, Inc. | Methods and devices for treating primary headache |
US11623080B2 (en) | 2005-11-10 | 2023-04-11 | Electrocore, Inc | Vagal nerve stimulation for treating dopamine-related conditions |
US10213601B2 (en) | 2005-11-10 | 2019-02-26 | Electrocore, Inc. | Non-invasive vagus nerve stimulation devices and methods to treat or avert atrial fibrillation |
US10441780B2 (en) | 2005-11-10 | 2019-10-15 | Electrocore, Inc. | Systems and methods for vagal nerve stimulation |
US11623079B2 (en) | 2005-11-10 | 2023-04-11 | Electrocore, Inc | Vagal nerve stimulation devices and methods for treating medical conditions |
US8812112B2 (en) | 2005-11-10 | 2014-08-19 | ElectroCore, LLC | Electrical treatment of bronchial constriction |
US11654277B2 (en) | 2005-11-10 | 2023-05-23 | Electrocore, Inc. | Nerve stimulation devices and methods |
US20070106338A1 (en) * | 2005-11-10 | 2007-05-10 | Electrocore, Inc. | Direct and Indirect Control of Muscle for the Treatment of Pathologies |
US20070106337A1 (en) * | 2005-11-10 | 2007-05-10 | Electrocore, Inc. | Methods And Apparatus For Treating Disorders Through Neurological And/Or Muscular Intervention |
US20110106479A1 (en) * | 2005-12-30 | 2011-05-05 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US9759678B2 (en) | 2005-12-30 | 2017-09-12 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
US9835580B2 (en) | 2005-12-30 | 2017-12-05 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
US9549698B2 (en) | 2005-12-30 | 2017-01-24 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US9360447B2 (en) | 2005-12-30 | 2016-06-07 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
US9885684B2 (en) | 2005-12-30 | 2018-02-06 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
US9976978B2 (en) | 2005-12-30 | 2018-05-22 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
US20110101995A1 (en) * | 2005-12-30 | 2011-05-05 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US20110106480A1 (en) * | 2005-12-30 | 2011-05-05 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US10288578B2 (en) | 2005-12-30 | 2019-05-14 | Medtronic Minimed, Inc | Methods and systems for detecting the hydration of sensors |
US10420496B2 (en) | 2005-12-30 | 2019-09-24 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US20070173712A1 (en) * | 2005-12-30 | 2007-07-26 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
US8010197B2 (en) | 2006-02-10 | 2011-08-30 | Electrocore Llc | Methods and apparatus for treating anaphylaxis using electrical modulation |
US8233988B2 (en) | 2006-02-10 | 2012-07-31 | Electrocore Llc | Electrical stimulation treatment of hypotension |
US7869879B2 (en) | 2006-02-10 | 2011-01-11 | Electrocore Llc | Electrical stimulation treatment of hypotension |
US7725188B2 (en) | 2006-02-10 | 2010-05-25 | Electrocore Llc | Electrical stimulation treatment of hypotension |
US7711430B2 (en) | 2006-02-10 | 2010-05-04 | Electrocore Llc | Methods and apparatus for treating anaphylaxis using electrical modulation |
US8612004B2 (en) | 2006-02-10 | 2013-12-17 | ElectroCore, LLC | Electrical stimulation treatment of hypotension |
US8041428B2 (en) | 2006-02-10 | 2011-10-18 | Electrocore Llc | Electrical stimulation treatment of hypotension |
US8483835B2 (en) | 2006-02-10 | 2013-07-09 | ElectroCore, LLC | Methods and apparatus for treating anaphylaxis using electrical modulation |
US8099167B1 (en) | 2006-02-10 | 2012-01-17 | Electrocore Llc | Methods and apparatus for treating anaphylaxis using electrical modulation |
US8204598B2 (en) | 2006-02-10 | 2012-06-19 | Electrocore Llc | Methods and apparatus for treating bronchial restriction using electrical modulation |
US20070239696A1 (en) * | 2006-03-28 | 2007-10-11 | Microsoft Corporation | Interactive relational graphic solutions |
US20080183237A1 (en) * | 2006-04-18 | 2008-07-31 | Electrocore, Inc. | Methods And Apparatus For Treating Ileus Condition Using Electrical Signals |
WO2007121424A2 (en) | 2006-04-18 | 2007-10-25 | Electrocore, Inc. | Methods and apparatus for treating ileus condition using electrical signals |
US8682449B2 (en) | 2008-04-10 | 2014-03-25 | ElectroCore, LLC | Methods and apparatus for transcranial stimulation |
US20090259274A1 (en) * | 2008-04-10 | 2009-10-15 | Electrocore, Inc. | Methods And Apparatus For Electrical Treatment Using Balloon And Electrode |
US8401650B2 (en) | 2008-04-10 | 2013-03-19 | Electrocore Llc | Methods and apparatus for electrical treatment using balloon and electrode |
US8666496B2 (en) | 2008-04-10 | 2014-03-04 | ElectroCore, LLC | Methods and apparatus for electrical treatment using balloon and electrode |
US8209034B2 (en) | 2008-12-18 | 2012-06-26 | Electrocore Llc | Methods and apparatus for electrical stimulation treatment using esophageal balloon and electrode |
US20100160996A1 (en) * | 2008-12-18 | 2010-06-24 | Electrocore, Inc. | Methods and apparatus for electrical stimulation treatment using esophageal balloon and electrode |
US10220207B2 (en) | 2009-03-20 | 2019-03-05 | Electrocore, Inc. | Nerve stimulation methods for averting imminent onset or episode of a disease |
US11197998B2 (en) | 2009-03-20 | 2021-12-14 | Electrocore, Inc. | Medical self-treatment using non-invasive vagus nerve stimulation |
US10232174B2 (en) | 2009-03-20 | 2019-03-19 | Electrocore, Inc. | Non-invasive electrical and magnetic nerve stimulators used to treat overactive bladder and urinary incontinence |
US11389103B2 (en) | 2009-03-20 | 2022-07-19 | Electrocore, Inc | Devices and methods for monitoring non-invasive vagus nerve stimulation |
US10252074B2 (en) | 2009-03-20 | 2019-04-09 | ElectroCore, LLC | Nerve stimulation methods for averting imminent onset or episode of a disease |
US10265523B2 (en) | 2009-03-20 | 2019-04-23 | Electrocore, Inc. | Non-invasive treatment of neurodegenerative diseases |
US20110152967A1 (en) * | 2009-03-20 | 2011-06-23 | ElectroCore, LLC. | Non-invasive treatment of neurodegenerative diseases |
US11298535B2 (en) | 2009-03-20 | 2022-04-12 | Electrocore, Inc | Non-invasive vagus nerve stimulation |
US10207106B2 (en) | 2009-03-20 | 2019-02-19 | ElectroCore, LLC | Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders |
US10286212B2 (en) | 2009-03-20 | 2019-05-14 | Electrocore, Inc. | Nerve stimulation methods for averting imminent onset or episode of a disease |
US11534600B2 (en) | 2009-03-20 | 2022-12-27 | Electrocore, Inc. | Non-invasive nerve stimulation to treat or prevent autism spectrum disorders and other disorders of psychological development |
US10232178B2 (en) | 2009-03-20 | 2019-03-19 | Electrocore, Inc. | Non-invasive magnetic or electrical nerve stimulation to treat or prevent dementia |
US10335593B2 (en) | 2009-03-20 | 2019-07-02 | Electrocore, Inc. | Devices and methods for monitoring non-invasive vagus nerve stimulation |
US20110230938A1 (en) * | 2009-03-20 | 2011-09-22 | ElectroCore, LLC. | Device and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation |
US11944815B2 (en) | 2009-03-20 | 2024-04-02 | Electrocore, Inc. | Non-invasive nerve stimulation with mobile device |
US11701515B2 (en) | 2009-03-20 | 2023-07-18 | Electrocore, Inc | Non-invasive nerve stimulation with mobile device |
US10376696B2 (en) | 2009-03-20 | 2019-08-13 | Electrocore, Inc. | Medical self-treatment using non-invasive vagus nerve stimulation |
US10512769B2 (en) | 2009-03-20 | 2019-12-24 | Electrocore, Inc. | Non-invasive magnetic or electrical nerve stimulation to treat or prevent autism spectrum disorders and other disorders of psychological development |
US10507325B2 (en) | 2009-03-20 | 2019-12-17 | Electrocore, Inc. | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
US8874205B2 (en) | 2009-03-20 | 2014-10-28 | ElectroCore, LLC | Device and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation |
US8868177B2 (en) | 2009-03-20 | 2014-10-21 | ElectroCore, LLC | Non-invasive treatment of neurodegenerative diseases |
US10639490B2 (en) | 2010-08-19 | 2020-05-05 | Electrocore, Inc. | Non-invasive treatment of bronchial construction |
US11324943B2 (en) | 2010-08-19 | 2022-05-10 | Electrocore, Inc | Devices and methods for vagal nerve stimulation |
US11623078B2 (en) | 2010-08-19 | 2023-04-11 | Electrocore, Inc | Devices and methods for non-invasive vagal nerve stimulation |
US11779756B2 (en) | 2010-08-19 | 2023-10-10 | Electrocore, Inc. | Systems and methods for vagal nerve stimulation |
US10363415B2 (en) | 2010-08-19 | 2019-07-30 | Electrocore, Inc. | Devices and methods for non-invasive electrical stimulation and their use for Vagal nerve stimulation |
US11458325B2 (en) | 2010-08-19 | 2022-10-04 | Electrocore, Inc | Non-invasive nerve stimulation to patients |
WO2012024169A2 (en) | 2010-08-19 | 2012-02-23 | Electrocore Llc | Non-invasive treatment of bronchial constriction |
US11400288B2 (en) | 2010-08-19 | 2022-08-02 | Electrocore, Inc | Devices and methods for electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
US11389646B2 (en) | 2010-08-19 | 2022-07-19 | Electrocore, Inc | Systems and methods for treating headache with vagal nerve stimulation |
US11191953B2 (en) | 2010-08-19 | 2021-12-07 | Electrocore, Inc. | Systems and methods for vagal nerve stimulation |
US11944807B2 (en) | 2010-08-19 | 2024-04-02 | Electrocore, Inc. | Vagal nerve stimulation for treating central nervous system disorders |
US11865329B2 (en) | 2010-08-19 | 2024-01-09 | Electrocore, Inc. | Vagal nerve stimulation for treating post-traumatic stress disorder |
US11123545B2 (en) | 2010-08-19 | 2021-09-21 | Electrocore, Inc. | Devices and methods for nerve stimulation |
US11141582B2 (en) | 2010-08-19 | 2021-10-12 | Electrocore, Inc | Devices and methods for nerve stimulation |
US11147961B2 (en) | 2010-08-19 | 2021-10-19 | Electrocore, Inc. | Devices and methods for nerve stimulation |
EP2605827A4 (en) * | 2010-08-19 | 2015-08-05 | Electrocore Llc | Non-invasive treatment of bronchial constriction |
US11850056B2 (en) | 2011-01-12 | 2023-12-26 | Electrocore, Inc. | Devices and methods for remote therapy and patient monitoring |
US11432760B2 (en) | 2011-01-12 | 2022-09-06 | Electrocore, Inc. | Devices and methods for remote therapy and patient monitoring |
US11458297B2 (en) | 2011-03-10 | 2022-10-04 | Electrocore, Inc | Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders |
US10279163B2 (en) | 2011-03-10 | 2019-05-07 | Electrocore, Inc. | Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders |
US10173048B2 (en) | 2011-03-10 | 2019-01-08 | Electrocore, Inc. | Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders |
US10384059B2 (en) | 2011-03-10 | 2019-08-20 | Electrocore, Inc. | Non-invasive vagal nerve stimulation to treat disorders |
US11517742B2 (en) | 2011-03-10 | 2022-12-06 | Electrocore, Inc | Non-invasive vagal nerve stimulation to treat disorders |
US11511109B2 (en) | 2011-03-10 | 2022-11-29 | Electrocore, Inc. | Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders |
EP2962724A1 (en) | 2011-03-10 | 2016-01-06 | Electrocore LLC | Device with enclosure for nerve modulation |
EP2962725A1 (en) | 2011-03-10 | 2016-01-06 | Electrocore LLC | Apparatus for nerve modulation |
EP3666325A1 (en) | 2011-03-10 | 2020-06-17 | Electrocore LLC | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
US11439818B2 (en) | 2011-03-10 | 2022-09-13 | Electrocore, Inc. | Electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders |
US10286211B2 (en) | 2011-08-31 | 2019-05-14 | Electrocore, Inc. | Systems and methods for vagal nerve stimulation |
US11612758B2 (en) | 2012-07-05 | 2023-03-28 | Btl Medical Solutions A.S. | Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields |
EP3854450A1 (en) | 2012-09-05 | 2021-07-28 | electroCore, Inc. | Non-invasive vagal nerve stimulation to treat disorders |
US11766562B2 (en) | 2013-01-15 | 2023-09-26 | Electrocore, Inc. | Nerve stimulator for use with a mobile device |
US10293160B2 (en) | 2013-01-15 | 2019-05-21 | Electrocore, Inc. | Mobile phone for treating a patient with dementia |
US10232177B2 (en) | 2013-01-15 | 2019-03-19 | ElectroCore, LLC | Mobile phone using non-invasive nerve stimulation |
US11020591B2 (en) | 2013-01-15 | 2021-06-01 | Electrocore, Inc. | Nerve stimulator for use with a mobile device |
US11406825B2 (en) | 2013-01-15 | 2022-08-09 | Electrocore, Inc | Mobile phone for treating a patient with dementia |
US11839764B2 (en) | 2013-01-15 | 2023-12-12 | Electrocore, Inc. | Systems and methods for treating a medical condition with an electrical stimulation treatment regimen |
US10874857B2 (en) | 2013-01-15 | 2020-12-29 | Electrocore, Inc | Mobile phone using non-invasive nerve stimulation |
US11065444B2 (en) | 2013-01-15 | 2021-07-20 | Electrocore, Inc. | Mobile phone for stimulating the trigeminal nerve to treat disorders |
US11446491B2 (en) | 2013-01-15 | 2022-09-20 | Electrocore, Inc | Stimulator for use with a mobile device |
US11097102B2 (en) | 2013-01-15 | 2021-08-24 | Electrocore, Inc. | Mobile phone using non-invasive nerve stimulation |
US11229790B2 (en) | 2013-01-15 | 2022-01-25 | Electrocore, Inc. | Mobile phone for treating a patient with seizures |
US10376695B2 (en) | 2013-01-15 | 2019-08-13 | Electrocore, Inc. | Mobile phone for stimulating the trigeminal nerve to treat disorders |
US11679258B2 (en) | 2013-01-15 | 2023-06-20 | Electrocore, Inc. | Stimulator for use with a mobile device |
US11260225B2 (en) | 2013-01-15 | 2022-03-01 | Electrocore, Inc | Nerve stimulator for use with a mobile device |
US10201705B2 (en) | 2013-03-15 | 2019-02-12 | Pacesetter, Inc. | Erythropoeitin production by electrical stimulation |
US9610444B2 (en) | 2013-03-15 | 2017-04-04 | Pacesetter, Inc. | Erythropoeitin production by electrical stimulation |
US10350411B2 (en) | 2013-04-28 | 2019-07-16 | Electrocore, Inc. | Devices and methods for treating medical disorders with evoked potentials and vagus nerve stimulation |
US11027127B2 (en) | 2013-04-28 | 2021-06-08 | Electrocore, Inc | Devices and methods for treating medical disorders with evoked potentials and vagus nerve stimulation |
US10363419B2 (en) | 2013-11-04 | 2019-07-30 | Electrocore, Inc. | Nerve stimulator system |
US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
US11253718B2 (en) | 2015-07-01 | 2022-02-22 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
US11266850B2 (en) | 2015-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US11602629B2 (en) | 2016-05-03 | 2023-03-14 | Btl Healthcare Technologies A.S. | Systems and methods for treatment of a patient including rf and electrical energy |
US11883643B2 (en) | 2016-05-03 | 2024-01-30 | Btl Healthcare Technologies A.S. | Systems and methods for treatment of a patient including RF and electrical energy |
US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US11691024B2 (en) | 2016-05-10 | 2023-07-04 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11590356B2 (en) | 2016-05-10 | 2023-02-28 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11464994B2 (en) | 2016-05-10 | 2022-10-11 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11623083B2 (en) | 2016-05-23 | 2023-04-11 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
US11878162B2 (en) | 2016-05-23 | 2024-01-23 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
US11458307B2 (en) | 2016-05-23 | 2022-10-04 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
US11185690B2 (en) | 2016-05-23 | 2021-11-30 | BTL Healthcare Technologies, a.s. | Systems and methods for tissue treatment |
US11896821B2 (en) | 2016-05-23 | 2024-02-13 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
US11524171B2 (en) | 2016-07-01 | 2022-12-13 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11679270B2 (en) | 2016-07-01 | 2023-06-20 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11484727B2 (en) | 2016-07-01 | 2022-11-01 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11628308B2 (en) | 2016-07-01 | 2023-04-18 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11794029B2 (en) | 2016-07-01 | 2023-10-24 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11497925B2 (en) | 2016-07-01 | 2022-11-15 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11266852B2 (en) | 2016-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11607556B2 (en) | 2016-07-01 | 2023-03-21 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
WO2019123395A1 (en) * | 2017-12-20 | 2019-06-27 | Panacea Quantum Leap Technology Llc | Tissue-stimulation device with output demultiplexer |
US11660461B2 (en) | 2017-12-20 | 2023-05-30 | Panacea Quantum Leap Technology Llc | Tissue-stimulation device with output demultiplexer |
US11247063B2 (en) | 2019-04-11 | 2022-02-15 | Btl Healthcare Technologies A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
US11484725B2 (en) | 2019-04-11 | 2022-11-01 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
US11424755B2 (en) | 2019-10-11 | 2022-08-23 | Regents Of The University Of Minnesota | System and method for a super-resolution digital-to-analog converter based on redundant sensing |
US11824555B2 (en) | 2019-10-11 | 2023-11-21 | Regents Of The University Of Minnesota | System and method for a super-resolution digital-to-analog converter based on redundant sensing |
US11826565B2 (en) | 2020-05-04 | 2023-11-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
US11813451B2 (en) | 2020-05-04 | 2023-11-14 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
US11806528B2 (en) | 2020-05-04 | 2023-11-07 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
WO2021243247A1 (en) * | 2020-05-28 | 2021-12-02 | Musc Foundation For Research Development | Noninvasive cranial nerve therapy |
US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
Also Published As
Publication number | Publication date |
---|---|
US6684106B2 (en) | 2004-01-27 |
US20020143365A1 (en) | 2002-10-03 |
WO1999037359A1 (en) | 1999-07-29 |
AU2350799A (en) | 1999-08-09 |
US6029090A (en) | 2000-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6684106B2 (en) | Method and electronic components for multi-functional electrical stimulation systems | |
US7463931B2 (en) | Electrical stimulation of tissue for therapeutic and diagnostic purposes | |
US7228178B2 (en) | Surface stimulation for tremor control | |
Clark et al. | The average response computer (ARC): a digital device for computing averages and amplitude and time histograms of electrophysiological response | |
Seidl et al. | CMOS-based high-density silicon microprobe arrays for electronic depth control in intracortical neural recording–characterization and application | |
WO2002087410A2 (en) | Diagnosis, treatment and research of mental disorders | |
JP2012508611A (en) | Shielded stimulation and detection system and method | |
US20060089751A1 (en) | Electronic delivery systems and methods with feedback | |
Nag et al. | Flexible charge balanced stimulator with 5.6 fC accuracy for 140 nC injections | |
Liu et al. | Active books: The design of an implantable stimulator that minimizes cable count using integrated circuits very close to electrodes | |
EP2844336B1 (en) | Electrode selection based on current source density analysis | |
Wheeler et al. | An implantable 64-channel neural interface with reconfigurable recording and stimulation | |
Mladejovsky et al. | A computer-based brain stimulation system to investigate sensory prostheses for the blind and deaf | |
US11865326B1 (en) | High precision, multi-output pulse and/or signal generators | |
JP2016086969A (en) | Nerve stimulation device and control method thereof | |
Castelli et al. | An IC-based controllable stimulator for respiratory muscle stimulation investigations | |
Kameda et al. | A multichannel current stimulator chip for spatiotemporal pattern stimulation of neural tissues | |
Lee et al. | A multi-channel neural recording system with adaptive electrode selection for high-density neural interface | |
Yao et al. | A low-profile three-dimensional neural stimulating array with on-chip current generation | |
Sugiura et al. | A programmable controller for spatio-temporal pattern stimulation of cortical visual prosthesis | |
Hayashida et al. | Multichannel stimulation module as a tool for animal studies on cortical neural prostheses | |
Loizou et al. | Open architecture research interface for cochlear implants | |
Liu et al. | Design of a stimulator ASIC for active electrode books | |
Kim et al. | On the design of a flexible stimulator for animal studies in auditory prostheses | |
Gkogkidis et al. | Neurophysiological Evaluation of a Customizable μECoG-based Wireless Brain Implant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |
|
AS | Assignment |
Owner name: INNOVATIONS HOLDINGS, L.L.C., NEW JERSEY Free format text: ASSIGNMENT CONFIRMATION;ASSIGNOR:HERBST, EWA;REEL/FRAME:022296/0576 Effective date: 20090117 |
|
AS | Assignment |
Owner name: INNOVATIONS HOLDINGS, L.L.C., NEW JERSEY Free format text: CHANGE OF ADDRESS;ASSIGNOR:INNOVATIONS HOLDINGS, L.L.C.;REEL/FRAME:036064/0433 Effective date: 20150616 |